Community Health Systems, Inc(NYSE:CYH)

Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as ski...
Website: http://www.chs.net
Founded: 1985
Full Time Employees: 63,000
Sector: Healthcare
Industry: Medical Care Facilities
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2017-03-31 | 2016-03-31 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net operating revenues | 3,106,000,000 | 3,087,000,000 | 3,133,000,000 | 3,159,000,000 | 3,265,000,000 | 3,090,000,000 | 3,108,000,000 | 3,142,000,000 | 3,025,000,000 | 2,934,000,000 | 3,111,000,000 | 3,233,000,000 | 3,115,000,000 | 3,007,000,000 | 3,013,000,000 | 3,119,000,000 | 3,126,000,000 | 2,519,000,000 | 3,025,000,000 | 3,246,000,000 | 3,302,000,000 | 3,376,000,000 | 4,486,000,000 | 4,999,000,000 | 3,297,035,000 | 3,402,287,000 | 3,436,000,000 | 3,433,829,000 | 3,405,342,000 | 3,402,699,000 | 3,252,055,000 | 2,772,860,000 | 2,690,600,000 | 2,727,554,000 | 2,334,786,000 | 2,352,087,000 | 1,249,128,000 | 1,203,997,000 | 1,154,477,000 | 1,123,483,000 | 1,061,054,000 | 1,026,562,000 | 982,070,000 | 929,269,000 | 918,718,000 | 914,108,000 | 844,034,000 | ||||
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||
salaries and benefits | 1,356,000,000 | 1,356,000,000 | 1,327,000,000 | 1,372,000,000 | 1,364,000,000 | 1,359,000,000 | 1,365,000,000 | 1,358,000,000 | 1,352,000,000 | 1,295,000,000 | 1,325,000,000 | 1,337,000,000 | 1,336,000,000 | 1,266,000,000 | 1,303,000,000 | 1,357,000,000 | 1,365,000,000 | 1,282,000,000 | 1,408,000,000 | 1,469,000,000 | 1,488,000,000 | 1,542,000,000 | 2,061,000,000 | 2,317,000,000 | 1,524,975,000 | 1,421,311,000 | 1,393,151,000 | 1,384,096,000 | 1,402,121,000 | 963,495,500 | 1,303,389,000 | 1,091,726,000 | 1,079,376,000 | 1,087,770,000 | 966,741,000 | 951,500,000 | 495,085,000 | 486,336,000 | 463,271,000 | 450,137,000 | 420,147,000 | 407,668,000 | 389,196,000 | 371,881,000 | 365,097,000 | 362,788,000 | 338,442,000 | ||||
supplies | 446,000,000 | 460,000,000 | 469,000,000 | 489,000,000 | 507,000,000 | 469,000,000 | 507,000,000 | 498,000,000 | 492,000,000 | 487,000,000 | 499,000,000 | 521,000,000 | 529,000,000 | 500,000,000 | 491,000,000 | 524,000,000 | 523,000,000 | 418,000,000 | 498,000,000 | 526,000,000 | 539,000,000 | 558,000,000 | 749,000,000 | 799,000,000 | 498,579,000 | 467,864,000 | 459,146,000 | 449,279,000 | 464,156,000 | 328,041,750 | 443,113,000 | 383,142,000 | 377,586,000 | 386,409,000 | 340,882,000 | 318,506,000 | 146,033,000 | 140,508,000 | 131,795,000 | 130,036,000 | 125,700,000 | 122,820,000 | 114,644,000 | 110,481,000 | 110,429,000 | 113,569,000 | 103,839,000 | ||||
other operating expenses | 841,000,000 | 832,000,000 | 885,000,000 | 865,000,000 | 905,000,000 | 1,010,000,000 | 835,000,000 | 825,000,000 | 828,000,000 | 830,000,000 | 853,000,000 | 788,000,000 | 716,000,000 | 715,000,000 | 738,000,000 | 746,000,000 | 736,000,000 | 736,000,000 | 737,000,000 | 812,000,000 | 893,000,000 | 811,000,000 | 1,057,000,000 | 1,173,000,000 | 708,943,000 | 622,500,000 | 623,608,000 | 654,737,000 | 624,795,000 | 444,538,250 | 606,073,000 | 529,363,000 | 526,098,000 | 526,167,000 | 467,987,000 | 464,127,000 | 258,556,000 | 245,259,000 | 235,914,000 | 235,021,000 | 219,113,000 | 207,043,000 | 204,085,000 | 194,102,000 | 189,446,000 | 180,832,000 | 171,384,000 | ||||
lease cost and rent | 68,000,000 | 67,000,000 | 74,000,000 | 68,000,000 | 75,000,000 | 73,000,000 | 81,000,000 | 81,000,000 | 80,000,000 | 78,000,000 | 77,000,000 | 77,000,000 | 75,000,000 | 78,000,000 | 78,000,000 | 79,000,000 | 85,000,000 | 82,000,000 | 81,000,000 | 79,000,000 | 81,000,000 | 80,000,000 | |||||||||||||||||||||||||||||
depreciation and amortization | 109,000,000 | 108,000,000 | 105,000,000 | 105,000,000 | 129,000,000 | 117,000,000 | 132,000,000 | 136,000,000 | 137,000,000 | 133,000,000 | 128,000,000 | 132,000,000 | 137,000,000 | 133,000,000 | 138,000,000 | 134,000,000 | 139,000,000 | 141,000,000 | 144,000,000 | 151,000,000 | 153,000,000 | 153,000,000 | 236,000,000 | 298,000,000 | 174,354,000 | 171,628,000 | 161,515,000 | 161,376,000 | 160,677,000 | 113,044,750 | 151,119,000 | 130,507,000 | 124,942,000 | 122,715,000 | 105,809,000 | 106,435,000 | 53,349,000 | 51,270,000 | 49,131,000 | 49,951,000 | 47,183,000 | 42,506,000 | 43,793,000 | 40,490,000 | 40,483,000 | 40,246,000 | 39,312,000 | ||||
impairment and loss on sale of businesses | -164,000,000 | 21,000,000 | -239,000,000 | 7,000,000 | 267,000,000 | 17,000,000 | 47,000,000 | 1,000,000 | 2,000,000 | 21,000,000 | 12,000,000 | -7,000,000 | 10,000,000 | 45,000,000 | 250,000,000 | ||||||||||||||||||||||||||||||||||||
total operating expenses | 2,656,000,000 | 2,844,000,000 | 2,621,000,000 | 2,875,000,000 | 2,987,000,000 | 3,295,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
income from operations | 450,000,000 | 243,000,000 | 512,000,000 | 284,000,000 | 278,000,000 | -205,000,000 | 210,000,000 | 229,000,000 | 204,000,000 | 119,000,000 | 270,000,000 | 424,000,000 | 340,000,000 | 314,000,000 | 326,000,000 | 436,000,000 | 285,000,000 | 296,000,000 | 110,000,000 | 184,000,000 | 111,000,000 | 189,000,000 | 71,000,000 | 294,000,000 | 349,128,000 | 280,993,000 | 283,803,000 | 288,908,000 | 280,965,000 | 282,325,000 | 280,819,000 | 253,067,000 | 233,074,000 | 247,556,000 | 55,648,000 | 192,648,000 | 118,575,000 | 118,736,000 | 115,207,000 | 40,808,000 | 109,106,000 | 115,339,000 | 107,591,000 | 96,292,000 | 98,552,000 | 100,964,000 | 81,625,000 | ||||
yoy | 61.87% | -218.54% | -197.62% | -22.22% | -45.99% | -40.00% | -62.10% | -17.18% | -2.75% | 19.30% | 6.08% | 196.36% | 136.96% | 156.76% | 56.61% | 159.15% | -62.24% | -45.87% | -74.98% | 1.76% | 24.26% | -0.47% | 1.06% | 14.16% | 20.55% | 14.04% | 404.63% | 31.36% | 96.56% | 108.49% | -51.70% | 372.08% | 8.68% | 2.95% | 7.08% | -57.62% | 10.71% | 14.24% | 31.81% | ||||||||||||
qoq | 85.19% | -52.54% | 80.28% | 2.16% | -235.61% | -8.30% | 12.25% | 71.43% | -55.93% | -36.32% | 24.71% | 8.28% | -3.68% | -25.23% | 52.98% | -3.72% | 169.09% | -40.22% | 65.77% | -41.27% | -75.85% | -15.79% | 24.25% | -0.99% | -1.77% | 2.83% | -0.48% | 0.54% | 10.97% | 8.58% | -5.85% | 344.86% | -71.11% | 62.47% | -0.14% | 3.06% | 182.31% | -62.60% | -5.40% | 7.20% | 11.73% | -2.29% | -2.39% | 23.69% | |||||||
interest expense | 162,250,000 | 216,000,000 | 214,000,000 | 219,000,000 | 160,750,000 | 216,000,000 | 207,000,000 | 163,000,000 | 217,000,000 | 218,000,000 | 217,000,000 | 166,500,000 | 216,000,000 | 219,000,000 | 231,000,000 | 194,750,000 | 257,000,000 | 260,000,000 | 262,000,000 | 259,000,000 | 265,000,000 | 257,000,000 | 229,000,000 | 251,000,000 | 152,175,000 | 121,482,000 | 159,480,000 | 163,230,000 | 164,172,000 | 121,577,000 | 164,011,000 | 167,785,000 | 154,361,000 | 165,702,000 | 50,266,500 | 139,507,000 | 31,155,000 | 30,404,000 | 18,287,750 | 27,494,000 | 23,870,000 | 21,787,000 | 17,490,750 | 24,170,000 | 23,012,000 | 22,781,000 | 19,159,000 | ||||
loss from early extinguishment of debt | -26,250,000 | 33,000,000 | -180,000,000 | -78,000,000 | 8,000,000 | 71,000,000 | -27,750,000 | -115,000,000 | 4,000,000 | 21,000,000 | 63,429,000 | 1,328,000 | 97,000 | 27,291,000 | 788,000 | ||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated affiliates | -4,000,000 | -2,000,000 | -2,000,000 | -3,000,000 | -2,000,000 | -3,000,000 | -3,000,000 | -5,000,000 | -1,000,000 | -5,000,000 | -3,000,000 | -4,000,000 | -4,000,000 | -10,000,000 | 1,000,000 | -5,000,000 | 1,000,000 | -7,000,000 | -3,000,000 | -20,000,000 | -12,013,000 | -11,146,000 | -8,194,000 | -12,017,000 | -18,130,000 | -8,275,000 | -9,535,000 | -8,691,000 | -10,508,000 | -12,884,000 | -10,828,000 | -14,304,000 | |||||||||||||||||||
income before income taxes | 221,000,000 | -2,000,000 | 438,000,000 | 67,000,000 | 64,000,000 | -419,000,000 | 6,000,000 | 325,000,000 | 70,000,000 | -98,000,000 | 53,000,000 | 221,000,000 | 154,000,000 | 91,000,000 | 34,000,000 | 389,000,000 | 148,000,000 | 35,000,000 | -149,000,000 | -72,000,000 | -149,000,000 | -94,000,000 | |||||||||||||||||||||||||||||
benefit from income taxes | -3,250,000 | -173,000,000 | 42,000,000 | 26,000,000 | 23,000,000 | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
net income | 160,000,000 | 171,000,000 | 320,000,000 | 25,000,000 | -28,000,000 | -355,000,000 | -20,000,000 | 446,000,000 | -298,000,000 | 30,000,000 | 222,000,000 | 144,000,000 | 37,000,000 | -35,000,000 | 353,000,000 | 128,000,000 | 93,000,000 | 34,000,000 | 2,000,000 | -146,000,000 | -101,000,000 | -177,000,000 | 36,000,000 | 99,252,000 | 53,120,000 | 92,631,000 | 53,547,000 | 78,325,000 | 92,249,000 | 84,854,000 | 50,384,000 | 47,893,000 | 60,127,000 | -88,258,000 | 10,460,000 | 53,763,000 | 54,324,000 | 53,615,000 | 8,241,000 | 52,369,000 | 54,038,000 | 48,142,000 | 42,886,000 | 40,528,000 | 35,988,000 | 32,039,000 | |||||
yoy | -671.43% | -148.17% | 1675.00% | -166.67% | 100.90% | NaN% | -905.41% | -185.71% | -37.11% | 12.50% | -60.22% | -202.94% | 17550.00% | -187.67% | -192.08% | -101.13% | -505.56% | -201.76% | -291.08% | -32.77% | 26.72% | -42.42% | 9.17% | 6.28% | 63.54% | 53.42% | -196.14% | 381.68% | -10.92% | 10.68% | -264.61% | 26.93% | 2.66% | 0.53% | 11.37% | -80.78% | 29.22% | 50.16% | 50.26% | ||||||||||||
qoq | -6.43% | -46.56% | 1180.00% | -189.29% | -92.11% | -104.48% | NaN% | NaN% | -1093.33% | -86.49% | 54.17% | 289.19% | -205.71% | -109.92% | 175.78% | 37.63% | 173.53% | 1600.00% | -101.37% | 44.55% | -591.67% | -63.73% | 86.84% | -42.65% | 72.99% | -31.63% | -15.09% | 8.71% | 68.41% | 5.20% | -20.35% | -168.13% | -943.77% | -80.54% | -1.03% | 1.32% | 550.59% | -84.26% | -3.09% | 12.25% | 12.26% | 5.82% | 12.62% | 12.33% | |||||||
less: net income attributable to noncontrolling interests | 50,000,000 | 41,000,000 | 38,000,000 | 38,000,000 | 42,000,000 | 36,000,000 | 31,000,000 | 31,000,000 | 42,000,000 | 28,000,000 | 31,000,000 | 44,000,000 | 33,000,000 | 31,000,000 | 29,000,000 | 42,000,000 | 16,000,000 | 23,000,000 | 16,000,000 | 19,000,000 | 21,000,000 | 17,000,000 | 22,000,000 | 25,000,000 | 23,778,000 | 22,189,000 | 18,327,000 | 18,158,000 | 17,001,000 | 11,429,750 | 14,453,000 | ||||||||||||||||||||
net income attributable to community health systems, inc. stockholders | 110,000,000 | 130,000,000 | 282,000,000 | -13,000,000 | -51,000,000 | 415,000,000 | -42,000,000 | -326,000,000 | -1,000,000 | 178,000,000 | 111,000,000 | 6,000,000 | -64,000,000 | 311,000,000 | 112,000,000 | 70,000,000 | 18,000,000 | -17,000,000 | -167,000,000 | -118,000,000 | -199,000,000 | 11,000,000 | |||||||||||||||||||||||||||||
earnings per share attributable to community health systems, inc. stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.82 | 0.97 | 2.11 | 3.21 | -0.32 | -2.52 | 1.41 | 0.87 | 0.04 | -0.51 | 2.69 | 0.98 | 0.61 | 0.15 | |||||||||||||||||||||||||||||||||||||
diluted | 0.8 | 0.96 | 2.09 | 3.21 | -0.32 | -2.52 | 1.36 | 0.85 | 0.04 | -0.51 | 2.65 | 0.97 | 0.61 | 0.15 | |||||||||||||||||||||||||||||||||||||
weighted-average number of shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 133,564,227 | 133,787,535 | 133,763,733 | 132,876,691 | 132,101,768 | 132,376,226 | 130,445,677 | 129,688,917 | 128,808,387 | 129,141,673 | 129,095,571 | 127,818,209 | 126,754,852 | 127,077,786 | 127,069,252 | 125,753,278 | 115,491,022 | 115,015,460 | 114,972,408 | 114,301,519 | 113,891,721 | 113,862,097 | 113,257,608 | 112,728,274 | 111,252,331 | 110,247,867 | 88,674,779 | 89,966,933 | 89,412,310 | 91,130,672 | 91,008,405 | 91,718,791 | 91,484,466 | 94,045,000 | 94,192,295,000 | 94,107,532,000 | 93,517,337,000 | 93,651,645,000 | 93,518,991,000 | 93,402,545,000 | 94,983,646,000 | 94,119,020,000 | 95,769,030,000 | 96,552,448,000 | 88,601,168,000 | 88,325,411,000 | 89,149,815,000 | 87,926,338,000 | 97,794,824,000 | ||
diluted | 135,012,240 | 135,187,592 | 134,882,981 | 132,876,691 | 132,101,768 | 132,376,226 | 130,445,677 | 129,688,917 | 130,060,319 | 129,141,673 | 129,095,571 | 127,818,209 | 130,597,410 | 130,885,139 | 130,737,124 | 125,753,278 | 116,544,561 | 115,640,852 | 115,013,661 | 114,379,331 | 113,891,721 | 113,862,097 | 113,257,608 | 112,728,274 | 111,252,331 | 110,309,372 | 88,852,704 | 90,666,348 | 89,857,583 | 91,783,725 | 92,136,819 | 92,946,048 | 92,462,702 | 95,160,000 | 95,513,127,000 | 95,006,721,000 | 94,642,294,000 | 94,841,749,000 | 94,647,870,000 | 94,365,292,000 | 96,232,910,000 | 95,258,771,000 | 96,870,315,000 | 98,209,271,000 | 98,579,977,000 | 98,528,968,000 | 99,328,929,000 | 98,087,086,000 | 107,869,639,000 | ||
gain from early extinguishment of debt | -138,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
provision for income taxes | 118,000,000 | 92,000,000 | -64,000,000 | -121,000,000 | 70,000,000 | 200,000,000 | -1,000,000 | 10,000,000 | 54,000,000 | 69,000,000 | -55,250,000 | 20,000,000 | -58,000,000 | -183,000,000 | 26,000,000 | 45,819,000 | 12,023,000 | 36,717,000 | 44,821,000 | 43,782,000 | 30,800,750 | 41,489,000 | 32,191,000 | 31,148,000 | 32,235,000 | -34,270,000 | 9,580,000 | 33,657,000 | 34,008,000 | 32,444,000 | 5,073,000 | 32,867,000 | 36,298,000 | 32,098,000 | 28,056,000 | 29,390,000 | 30,491,000 | 24,029,000 | |||||||||||||
impairment and (gain) loss on sale of businesses | -24,000,000 | -22,000,000 | 6,000,000 | 33,000,000 | 38,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
loss per share attributable to community health systems, inc. stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.1 | -0.845 | -2.95 | -0.4 | -0.01 | -0.15 | -1.47 | -1.04 | |||||||||||||||||||||||||||||||||||||||||||
diluted | -0.1 | -0.845 | -2.95 | -0.4 | -0.01 | -0.15 | -1.47 | -1.04 | |||||||||||||||||||||||||||||||||||||||||||
net loss attributable to community health systems, inc. stockholders | -111,500,000 | -391,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income, net of income taxes: | |||||||||||||||||||||||||||||||||||||||||||||||||||
net change in fair value of available-for-sale debt securities, net of tax | 1 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||
amortization and recognition of unrecognized pension cost components, net of tax | 0.5 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | 1.5 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive loss | -82 | -351 | |||||||||||||||||||||||||||||||||||||||||||||||||
less: comprehensive income attributable to noncontrolling interests | 28 | 36 | |||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive loss attributable to community health systems, inc. stockholders | -110 | -387 | |||||||||||||||||||||||||||||||||||||||||||||||||
medicare | 471,000,000 | 608,000,000 | 628,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
medicare managed care | 390,750,000 | 498,000,000 | 522,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
medicaid | 332,000,000 | 456,000,000 | 449,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
managed care and other third-party payors | 1,110,250,000 | 1,479,000,000 | 1,492,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
self-pay | 23,000,000 | 45,000,000 | 24,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
total | 2,327,000,000 | 3,086,000,000 | 3,115,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
effect on income before income taxes | -4,000,000 | -6,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
effect on net income | -3,250,000 | -5,000,000 | -3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
operating costs and expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||
pandemic relief funds | -2,000,000 | -115,000,000 | -8,000,000 | -47,000,000 | -46,000,000 | -19,000,000 | -1,000,000 | -82,000,000 | -153,000,000 | -448,000,000 | |||||||||||||||||||||||||||||||||||||||||
total operating costs and expenses | 2,898,000,000 | 2,913,000,000 | 2,821,000,000 | 2,815,000,000 | 2,841,000,000 | 2,809,000,000 | 2,775,000,000 | 2,693,000,000 | 2,687,000,000 | 2,683,000,000 | 2,841,000,000 | 2,223,000,000 | 2,915,000,000 | 3,062,000,000 | 3,191,000,000 | 3,187,000,000 | 4,415,000,000 | 4,705,000,000 | 2,947,907,000 | 3,121,294,000 | 3,152,197,000 | 3,144,921,000 | 3,124,377,000 | 2,187,799,500 | 2,971,236,000 | 2,519,793,000 | 2,457,526,000 | 2,479,998,000 | 2,279,138,000 | 2,159,439,000 | 1,130,553,000 | 1,085,261,000 | 1,039,270,000 | 1,082,675,000 | 951,948,000 | 911,223,000 | 874,479,000 | 832,977,000 | 820,166,000 | 813,144,000 | 762,409,000 | ||||||||||
income from early extinguishment of debt | 5,000,000 | 31,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of equity interests in macon healthcare, llc | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share attributable to community health systems, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.1 | -0.845 | -2.95 | -0.4 | -0.01 | -0.15 | -1.47 | -1.04 | |||||||||||||||||||||||||||||||||||||||||||
diluted | -0.1 | -0.845 | -2.95 | -0.4 | -0.01 | -0.15 | -1.47 | -1.04 | |||||||||||||||||||||||||||||||||||||||||||
government and other legal settlements and related costs | 1,000,000 | 2,000,000 | 2,000,000 | 26,000,000 | 4,000,000 | 5,000,000 | -41,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
gain on sale of investments in unconsolidated affiliates | -6,500,000 | -26,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to community health systems, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.82 | 0.97 | 2.11 | 3.21 | -0.32 | -2.52 | 1.41 | 0.87 | 0.04 | -0.51 | 2.69 | 0.98 | 0.61 | 0.15 | |||||||||||||||||||||||||||||||||||||
diluted | 0.8 | 0.96 | 2.09 | 3.21 | -0.32 | -2.52 | 1.36 | 0.85 | 0.04 | -0.51 | 2.65 | 0.97 | 0.61 | 0.15 | |||||||||||||||||||||||||||||||||||||
see accompanying notes to the condensed consolidated financial statements. | |||||||||||||||||||||||||||||||||||||||||||||||||||
electronic health records incentive reimbursement | -6,000,000 | -18,000,000 | -26,168,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
(benefit from) benefit from income taxes | -74,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
operating revenues | 5,168,000,000 | 5,754,000,000 | 3,783,491,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
provision for bad debts | 682,000,000 | 755,000,000 | 486,456,000 | 436,689,000 | 450,296,000 | 433,002,000 | 407,871,000 | 290,650,250 | 403,077,000 | 326,213,000 | 291,045,000 | 297,080,000 | 335,515,000 | 279,604,000 | 148,661,000 | 135,699,000 | 132,047,000 | 192,439,000 | 115,704,000 | 107,591,000 | 99,983,000 | 92,980,000 | 91,582,000 | 93,994,000 | 88,401,000 | ||||||||||||||||||||||||||
rent | 109,000,000 | 119,000,000 | 67,224,000 | 64,699,000 | 64,481,000 | 62,431,000 | 64,757,000 | 48,029,000 | 64,465,000 | 58,842,000 | 58,479,000 | 59,857,000 | 53,229,000 | 49,060,000 | 28,244,000 | 25,996,000 | 25,986,000 | 24,490,000 | 23,646,000 | 22,982,000 | 22,393,000 | 22,328,000 | 22,012,000 | 20,828,000 | 20,951,000 | ||||||||||||||||||||||||||
income from continuing operations before income taxes | -176,000,000 | 63,000,000 | 145,537,000 | 67,638,000 | 132,517,000 | 137,695,000 | 134,923,000 | 94,848,750 | 126,343,000 | 83,613,000 | 80,904,000 | 83,728,000 | -98,780,000 | 25,850,000 | 87,420,000 | 88,332,000 | 86,059,000 | 13,314,000 | 85,236,000 | 93,552,000 | 82,941,000 | 72,122,000 | 75,540,000 | 78,183,000 | 61,678,000 | ||||||||||||||||||||||||||
income from continuing operations | -176,000,000 | 37,000,000 | 99,718,000 | 55,615,000 | 95,800,000 | 92,874,000 | 91,141,000 | 92,249,000 | 84,854,000 | 51,422,000 | 49,756,000 | 51,493,000 | -64,510,000 | 16,270,000 | 53,763,000 | 54,324,000 | 53,615,000 | 8,241,000 | 52,369,000 | 57,254,000 | 50,843,000 | 44,066,000 | 46,150,000 | 47,692,000 | 37,649,000 | ||||||||||||||||||||||||||
discontinued operations, net of taxes: | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of entities sold or held for sale | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals sold or held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations, net of taxes | -1,000,000 | -466,000 | -13,944,000 | -3,169,000 | -39,327,000 | ||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share attributable to community health systems, inc. common stockholders | |||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | -1.78 | 0.11 | 0.86 | 0.38 | 0.87 | 0.82 | 0.81 | 0.76 | 0.77 | ||||||||||||||||||||||||||||||||||||||||||
discontinued operations | -0.01 | -0.01 | -0.01 | -0.03 | -0.04 | -0.43 | -0.14 | ||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share attributable to community health systems, inc. common stockholders | |||||||||||||||||||||||||||||||||||||||||||||||||||
government settlement and related costs | |||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 17,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale | 728,000 | -66,000 | -3,234,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share attributable to community | |||||||||||||||||||||||||||||||||||||||||||||||||||
health systems, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share attributable to community | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of entities sold | -466,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospital sold | |||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to community health systems, inc. | 75,474,000 | 30,931,000 | 74,304,000 | 35,389,000 | 61,324,000 | 52,618,250 | 70,401,000 | ||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share attributable to community health systems, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share attributable to community health systems, inc. common stockholders : | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of entities sold and held for sale | -1,136,500 | -3,103,000 | -1,214,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals sold and held for sale | -11,982,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||
total per share amounts may not add due to rounding. | |||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations of entities sold and held for sale | 235,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals held for sale | -39,562,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share attributable to community health systems, inc. common stockholders : | |||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets of hospital held for sale | -8,368,000 | -4,471,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations | -12,816,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations of hospitals sold and hospitals held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospitals | -639,750 | -2,559,000 | -1,904,500 | -7,618,000 | |||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share attributable to community health systems, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||
minority interest in earnings | 10,360,000 | 8,317,000 | 9,682,000 | 10,667,000 | 4,511,000 | 625,000 | 193,000 | 1,126,000 | 601,000 | 455,000 | 613,000 | 385,000 | 715,000 | 1,117,000 | 887,000 | 80,000 | |||||||||||||||||||||||||||||||||||
loss from operations of hospitals sold and hospitals held for sale | -1,038,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of hospitals and partnership interest | |||||||||||||||||||||||||||||||||||||||||||||||||||
income on discontinued operations | -1,038,000 | -1,863,000 | 8,634,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 550 | 530 | 550 | 332.5 | 170 | 570 | 580 | 307.5 | 90 | 550 | 590 | 392.5 | 500 | 520 | 540 | 390 | |||||||||||||||||||||||||||||||||||
diluted | 540 | 520 | 540 | 330 | 170 | 570 | 580 | 305 | 90 | 540 | 580 | 370 | 470 | 490 | 510 | 370 | |||||||||||||||||||||||||||||||||||
net income per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 540 | 510 | 640 | 317.5 | 110 | 570 | 580 | 300 | 90 | 550 | 560 | 337.5 | 490 | 450 | 410 | 330 | |||||||||||||||||||||||||||||||||||
diluted | 530 | 500 | 630 | 312.5 | 110 | 570 | 580 | 297.5 | 90 | 540 | 550 | 320 | 460 | 430 | 390 | 320 | |||||||||||||||||||||||||||||||||||
income from operations of hospitals sold and hospital held for sale | -1,854,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of hospitals | -9,000 | 9,617,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of hospitals sold and hospital held for sale | -983,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of hospitals held for sale and sale of partnership interest | -858,000 | -3,382,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospital and partnership interest | -607,000 | -2,428,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
loss on discontinued operations | -23,748,000 | -5,810,000 | -3,216,000 | -2,701,000 | -1,180,000 | -5,622,000 | -11,704,000 | ||||||||||||||||||||||||||||||||||||||||||||
loss from operations of hospital sold and held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of hospital sold | |||||||||||||||||||||||||||||||||||||||||||||||||||
loss from operations of hospitals sold and held for sale | -164,250 | -657,000 | -1,951,000 | -1,180,000 | -1,151,000 | ||||||||||||||||||||||||||||||||||||||||||||||
income from operations of hospitals sold or held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||
net loss on sale of hospitals | |||||||||||||||||||||||||||||||||||||||||||||||||||
(loss) income on discontinued operations |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-03-31 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 260,000,000 | 123,000,000 | 456,000,000 | 431,000,000 | 37,000,000 | 33,000,000 | 39,000,000 | 48,000,000 | 38,000,000 | 91,000,000 | 118,000,000 | 144,000,000 | 118,000,000 | 300,000,000 | 346,000,000 | 460,000,000 | 507,000,000 | 1,294,000,000 | 1,250,000,000 | 1,251,000,000 | 1,676,000,000 | 1,823,000,000 | 1,552,000,000 | 246,000,000 | 216,000,000 | 157,000,000 | 207,000,000 | 277,000,000 | 196,000,000 | 335,000,000 | 208,000,000 | 424,000,000 | 590,000,000 | 768,000,000 | 247,000,000 | 181,000,000 | 129,298,000 | 129,865,000 | 266,312,000 | 191,432,000 | 270,716,000 | 299,169,000 | 567,749,000 | 264,072,000 | 164,353,000 | 132,874,000 | 118,855,000 | 21,357,000 | 62,878,000 | 40,566,000 | 13,444,000 | 24,157,000 | 111,951,000 | 104,108,000 | 184,280,000 | 272,364,000 | 218,447,000 | 19,952,000 | |
patient accounts receivable | 2,077,000,000 | 2,159,000,000 | 2,261,000,000 | 2,326,000,000 | 2,286,000,000 | 2,043,000,000 | 2,195,000,000 | 2,194,000,000 | 2,231,000,000 | 2,160,000,000 | 2,043,000,000 | 2,043,000,000 | 2,040,000,000 | 1,969,000,000 | 2,001,000,000 | 2,079,000,000 | 2,062,000,000 | 2,024,000,000 | 1,958,000,000 | 1,961,000,000 | 1,927,000,000 | 1,956,000,000 | 1,925,000,000 | 2,100,000,000 | 2,258,000,000 | 2,269,000,000 | 2,356,000,000 | 2,360,000,000 | 2,352,000,000 | 2,347,000,000 | 2,407,000,000 | 2,453,000,000 | |||||||||||||||||||||||||||
supplies | 322,000,000 | 325,000,000 | 326,000,000 | 328,000,000 | 331,000,000 | 311,000,000 | 337,000,000 | 329,000,000 | 328,000,000 | 325,000,000 | 333,000,000 | 345,000,000 | 353,000,000 | 355,000,000 | 356,000,000 | 353,000,000 | 355,000,000 | 341,000,000 | 337,000,000 | 336,000,000 | 335,000,000 | 337,000,000 | 337,000,000 | 354,000,000 | 354,000,000 | 376,000,000 | 378,000,000 | 397,000,000 | 402,000,000 | 424,000,000 | 432,000,000 | 442,000,000 | 445,000,000 | 438,000,000 | 458,000,000 | 587,000,000 | 354,074,000 | 346,611,000 | 336,462,000 | 342,268,000 | 329,275,000 | 329,114,000 | 313,770,000 | 267,320,000 | 266,403,000 | 264,061,000 | 262,903,000 | 274,455,000 | 121,964,000 | 113,315,000 | 113,320,000 | 106,718,000 | 102,874,000 | 94,864,000 | 95,200,000 | 90,214,000 | 88,635,000 | 86,314,000 | 85,653,000 |
prepaid income taxes | 13,000,000 | 2,000,000 | 53,000,000 | 92,000,000 | 92,000,000 | 34,000,000 | 76,000,000 | 98,000,000 | 100,000,000 | 79,000,000 | 99,000,000 | 98,000,000 | 99,000,000 | 95,000,000 | 94,000,000 | 44,000,000 | 46,000,000 | 50,000,000 | 50,000,000 | 50,000,000 | 47,000,000 | 47,000,000 | 48,000,000 | 45,000,000 | 3,000,000 | 3,000,000 | 17,000,000 | 8,000,000 | 17,000,000 | 22,000,000 | 22,000,000 | 17,000,000 | 2,000,000 | 49,769,000 | 101,389,000 | 65,030,000 | 118,464,000 | 100,868,000 | 110,160,000 | 99,417,000 | |||||||||||||||||||
prepaid expenses | 181,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current assets | 381,000,000 | 325,000,000 | 351,000,000 | 61,000,000 | 358,000,000 | 402,000,000 | 292,000,000 | 307,000,000 | 275,000,000 | 325,000,000 | 339,000,000 | 227,000,000 | 235,000,000 | 301,000,000 | 264,000,000 | 272,000,000 | 269,000,000 | 285,000,000 | 284,000,000 | 316,000,000 | 338,000,000 | 360,000,000 | 374,000,000 | 425,000,000 | 358,000,000 | 341,000,000 | 366,000,000 | 361,000,000 | 400,000,000 | 410,000,000 | 422,000,000 | 449,000,000 | 526,000,000 | 678,000,000 | 671,000,000 | 545,000,000 | 328,847,000 | 231,647,000 | 225,737,000 | 175,109,000 | 176,545,000 | 193,331,000 | 171,906,000 | 197,787,000 | 191,226,000 | 244,567,000 | 339,826,000 | 233,338,000 | 62,933,000 | 49,354,000 | 47,880,000 | 55,287,000 | 49,608,000 | 53,455,000 | 21,367,000 | 19,903,000 | 16,253,000 | 15,132,000 | 19,642,000 |
total current assets | 3,234,000,000 | 3,198,000,000 | 3,659,000,000 | 3,407,000,000 | 3,301,000,000 | 3,108,000,000 | 3,199,000,000 | 3,175,000,000 | 3,208,000,000 | 3,248,000,000 | 3,192,000,000 | 3,114,000,000 | 3,082,000,000 | 3,269,000,000 | 3,329,000,000 | 3,488,000,000 | 3,479,000,000 | 4,177,000,000 | 4,053,000,000 | 4,104,000,000 | 4,510,000,000 | 4,692,000,000 | 4,413,000,000 | 3,360,000,000 | 3,427,000,000 | 3,382,000,000 | 3,484,000,000 | 3,595,000,000 | 3,549,000,000 | 3,724,000,000 | 3,694,000,000 | 3,993,000,000 | 4,678,000,000 | 5,055,000,000 | 4,775,000,000 | 5,256,000,000 | 3,100,476,000 | 2,846,089,000 | 2,836,528,000 | 2,734,490,000 | 2,835,993,000 | 2,871,193,000 | 2,983,970,000 | 2,652,151,000 | 2,503,658,000 | 2,606,392,000 | 2,552,898,000 | 2,709,784,000 | 1,132,313,000 | 1,092,005,000 | 1,021,384,000 | 961,960,000 | 939,643,000 | 995,910,000 | 914,209,000 | 960,791,000 | 1,021,549,000 | 956,194,000 | 738,186,000 |
property and equipment | 8,912,000,000 | 9,064,000,000 | 9,022,000,000 | 9,200,000,000 | 9,160,000,000 | 9,094,000,000 | 9,594,000,000 | 9,607,000,000 | 9,511,000,000 | 9,367,000,000 | 9,527,000,000 | 9,560,000,000 | 9,639,000,000 | 9,727,000,000 | 9,759,000,000 | 9,779,000,000 | 9,757,000,000 | 9,536,000,000 | 9,410,000,000 | 9,396,000,000 | 9,352,000,000 | 9,293,000,000 | 9,328,000,000 | 9,618,000,000 | 9,653,000,000 | 10,198,000,000 | 10,120,000,000 | 10,331,000,000 | 10,301,000,000 | 10,986,000,000 | 11,148,000,000 | 11,402,000,000 | 11,552,000,000 | 11,397,000,000 | 11,824,000,000 | 15,084,000,000 | 9,640,636,000 | 6,855,976,000 | 8,963,658,000 | 8,798,266,000 | 8,663,963,000 | 6,457,466,000 | 8,135,499,000 | 6,861,907,000 | 6,639,690,000 | 6,230,360,000 | 5,512,574,000 | 6,670,291,000 | 2,809,988,000 | 2,667,923,000 | 1,986,577,000 | 2,451,738,000 | 2,335,763,000 | 2,175,228,000 | 1,610,991,000 | 1,984,274,000 | 1,945,942,000 | 1,916,690,000 | 1,890,735,000 |
land and improvements | 399,000,000 | 427,000,000 | 474,000,000 | 497,000,000 | 534,000,000 | 515,000,000 | 560,000,000 | 597,000,000 | 591,457,000 | 547,201,000 | 460,501,000 | 163,988,000 | 121,637,000 | ||||||||||||||||||||||||||||||||||||||||||||||
buildings and improvements | 5,453,000,000 | 5,658,000,000 | 5,951,000,000 | 6,038,000,000 | 6,050,000,000 | 5,749,000,000 | 5,878,000,000 | 6,228,000,000 | 5,715,066,000 | 5,214,091,000 | 4,134,654,000 | 1,634,893,000 | 1,307,978,000 | ||||||||||||||||||||||||||||||||||||||||||||||
equipment and fixtures | 3,060,000,000 | 3,075,000,000 | 3,086,000,000 | 3,104,000,000 | 3,173,000,000 | 3,088,000,000 | 3,215,000,000 | 3,476,000,000 | 3,063,005,000 | 2,802,920,000 | 1,606,756,000 | 831,485,000 | 699,024,000 | ||||||||||||||||||||||||||||||||||||||||||||||
less accumulated depreciation and amortization | -4,409,000,000 | -4,444,000,000 | -4,365,000,000 | -4,458,000,000 | -4,384,000,000 | -4,130,000,000 | -4,372,000,000 | -4,388,000,000 | -4,304,000,000 | -4,207,000,000 | -4,277,000,000 | -4,305,000,000 | -4,274,000,000 | -4,277,000,000 | -4,220,000,000 | -4,223,000,000 | -4,204,000,000 | -4,168,000,000 | -4,085,000,000 | -4,091,000,000 | -4,030,000,000 | -4,003,000,000 | -4,019,000,000 | -4,096,000,000 | -4,045,000,000 | -4,267,000,000 | -4,186,000,000 | -4,245,000,000 | -4,162,000,000 | -4,416,000,000 | -4,399,000,000 | -4,431,000,000 | -4,221,000,000 | -4,085,000,000 | -4,185,000,000 | -4,980,000,000 | -2,638,773,000 | -2,513,552,000 | -2,389,718,000 | -2,291,842,000 | -2,217,546,000 | -2,106,746,000 | -1,991,929,000 | -1,117,441,000 | -1,017,936,000 | -791,963,000 | -689,337,000 | -792,871,000 | -720,846,000 | -682,220,000 | -643,789,000 | -605,600,000 | -578,545,000 | -547,770,000 | -517,648,000 | -484,584,000 | -461,473,000 | -439,455,000 | |
goodwill | 3,316,000,000 | 3,540,000,000 | 3,604,000,000 | 3,785,000,000 | 3,789,000,000 | 3,940,000,000 | 3,972,000,000 | 3,957,000,000 | 3,958,000,000 | 3,943,000,000 | 4,054,000,000 | 4,051,000,000 | 4,166,000,000 | 4,201,000,000 | 4,224,000,000 | 4,219,000,000 | 4,219,000,000 | 4,219,000,000 | 4,219,000,000 | 4,219,000,000 | 4,219,000,000 | 4,220,000,000 | 4,225,000,000 | 4,322,000,000 | 4,328,000,000 | 4,495,000,000 | 4,494,000,000 | 4,553,000,000 | 4,559,000,000 | 4,631,000,000 | 4,653,000,000 | 4,704,000,000 | 6,148,000,000 | 6,165,000,000 | 6,327,000,000 | 9,022,000,000 | 4,367,841,000 | 4,264,845,000 | 4,232,913,000 | 4,227,970,000 | 4,225,768,000 | 4,199,905,000 | 4,174,040,000 | 4,151,487,000 | 4,165,041,000 | 4,375,293,000 | 4,247,714,000 | 4,046,813,000 | 1,344,956,000 | 1,332,422,000 | 1,336,525,000 | 1,381,137,000 | 1,316,939,000 | 1,267,557,000 | 1,259,816,000 | 1,236,623,000 | 1,217,513,000 | 1,205,120,000 | 1,213,479,000 |
deferred income taxes | 50,000,000 | 75,000,000 | 13,000,000 | 13,000,000 | 13,000,000 | 29,000,000 | 29,000,000 | 29,000,000 | 29,000,000 | 49,000,000 | 49,000,000 | 49,000,000 | 49,000,000 | 53,000,000 | 53,000,000 | 53,000,000 | 53,000,000 | 59,000,000 | 59,000,000 | 59,000,000 | 59,000,000 | 88,000,000 | 107,000,000 | 50,000,000 | 38,000,000 | 94,000,000 | 57,000,000 | 66,000,000 | 69,000,000 | 39,000,000 | 101,000,000 | 64,000,000 | 319,000,000 | 396,000,000 | 415,000,000 | 599,000,000 | 89,797,000 | 89,797,000 | 115,819,000 | 115,819,000 | 115,819,000 | 115,819,000 | 78,621,000 | 111,101,000 | 88,531,000 | 113,741,000 | 113,741,000 | 53,157,000 | 13,249,000 | 13,249,000 | 13,249,000 | 4,128,000 | 4,128,000 | 4,128,000 | 4,128,000 | 1,301,000 | 1,301,000 | 1,301,000 | 669,000 |
other assets, net of accumulated amortization of 1,317 and 1,501 at december 31, 2025 and 2024, respectively | 2,101,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total assets | 13,204,000,000 | 13,239,000,000 | 13,641,000,000 | 13,890,000,000 | 14,054,000,000 | 13,905,000,000 | 14,411,000,000 | 14,417,000,000 | 14,455,000,000 | 14,674,000,000 | 14,648,000,000 | 14,623,000,000 | 14,669,000,000 | 14,914,000,000 | 15,058,000,000 | 15,263,000,000 | 15,217,000,000 | 15,670,000,000 | 15,528,000,000 | 15,592,000,000 | 16,006,000,000 | 16,516,000,000 | 16,415,000,000 | 15,445,000,000 | 15,609,000,000 | 15,895,000,000 | 16,132,000,000 | 16,309,000,000 | 15,859,000,000 | 16,469,000,000 | 16,794,000,000 | 17,311,000,000 | 19,735,000,000 | 20,873,000,000 | 21,660,000,000 | 26,724,000,000 | 15,846,416,000 | 15,208,840,000 | 14,847,922,000 | 14,825,415,000 | 14,718,279,000 | 14,698,123,000 | 14,419,493,000 | 13,587,404,000 | 13,359,508,000 | 13,332,349,000 | 13,493,643,000 | 13,438,697,000 | 4,793,111,000 | 4,608,916,000 | 4,506,579,000 | 4,343,613,000 | 4,178,660,000 | 4,049,289,000 | 3,934,218,000 | 3,844,083,000 | 3,848,171,000 | 3,761,115,000 | 3,534,695,000 |
liabilities and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current maturities of long-term debt | 16,000,000 | 16,000,000 | 23,000,000 | 29,000,000 | 20,000,000 | 20,000,000 | 27,000,000 | 34,000,000 | 21,000,000 | 22,000,000 | 30,000,000 | 39,000,000 | 21,000,000 | 21,000,000 | 32,000,000 | 43,000,000 | 31,000,000 | 35,000,000 | 27,000,000 | 20,000,000 | 123,000,000 | 19,000,000 | 30,000,000 | 30,000,000 | 20,000,000 | 318,000,000 | 206,000,000 | 205,000,000 | 204,000,000 | 35,000,000 | 41,000,000 | 37,000,000 | 40,000,000 | 46,000,000 | 558,000,000 | 249,000,000 | 75,388,000 | 63,706,000 | 61,066,000 | 70,112,000 | 65,952,000 | 63,139,000 | 60,654,000 | 19,647,000 | 24,279,000 | 19,476,000 | 20,710,000 | 79,346,000 | 25,757,000 | 23,058,000 | 35,396,000 | 28,384,000 | 20,621,000 | 19,284,000 | 19,124,000 | 22,790,000 | 22,831,000 | 25,040,000 | 20,687,000 |
current operating lease liabilities | 110,000,000 | 110,000,000 | 112,000,000 | 112,000,000 | 115,000,000 | 113,000,000 | 114,000,000 | 115,000,000 | 124,000,000 | 121,000,000 | 134,000,000 | 138,000,000 | 148,000,000 | 151,000,000 | 153,000,000 | 149,000,000 | 147,000,000 | 142,000,000 | 134,000,000 | 131,000,000 | 142,000,000 | 131,000,000 | 135,000,000 | 132,000,000 | 136,000,000 | 137,000,000 | 133,000,000 | 143,000,000 | |||||||||||||||||||||||||||||||
accounts payable | 842,000,000 | 894,000,000 | 970,000,000 | 974,000,000 | 913,000,000 | 842,000,000 | 896,000,000 | 941,000,000 | 912,000,000 | 837,000,000 | 736,000,000 | 712,000,000 | 773,000,000 | 820,000,000 | 832,000,000 | 825,000,000 | 830,000,000 | 763,000,000 | 681,000,000 | 730,000,000 | 783,000,000 | 710,000,000 | 677,000,000 | 727,000,000 | 811,000,000 | 743,000,000 | 812,000,000 | 863,000,000 | 887,000,000 | 816,000,000 | 839,000,000 | 892,000,000 | 850,000,000 | 917,000,000 | 988,000,000 | 1,179,000,000 | 822,247,000 | 748,997,000 | 636,327,000 | 583,924,000 | 547,683,000 | 526,338,000 | 516,152,000 | 477,064,000 | 438,518,000 | 461,437,000 | 492,693,000 | 505,700,000 | 257,730,000 | 239,889,000 | 247,747,000 | 210,839,000 | 197,010,000 | 158,190,000 | 189,940,000 | 154,725,000 | 147,396,000 | 151,703,000 | 147,011,000 |
accrued liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
employee compensation | 569,000,000 | 468,000,000 | 486,000,000 | 478,000,000 | 596,000,000 | 460,000,000 | 499,000,000 | 504,000,000 | 571,000,000 | 513,000,000 | 560,000,000 | 596,000,000 | 637,000,000 | 601,000,000 | 624,000,000 | 697,000,000 | 655,000,000 | 687,000,000 | 600,000,000 | 667,000,000 | 637,000,000 | 580,000,000 | 492,000,000 | 593,000,000 | 594,000,000 | 592,000,000 | 549,000,000 | 628,000,000 | 627,000,000 | 630,000,000 | 592,000,000 | 668,000,000 | 620,508,000 | 596,026,000 | 403,598,000 | 162,188,000 | 121,775,000 | ||||||||||||||||||||||
accrued interest | 238,000,000 | 209,000,000 | 219,000,000 | 198,000,000 | 222,000,000 | 198,000,000 | 258,000,000 | 207,000,000 | 160,000,000 | 184,000,000 | 189,000,000 | 184,000,000 | 189,000,000 | 218,000,000 | 221,000,000 | 186,000,000 | 225,000,000 | 198,000,000 | 264,000,000 | 159,000,000 | 150,000,000 | 180,000,000 | 211,000,000 | 180,000,000 | 189,000,000 | 145,000,000 | 388,000,000 | 250,000,000 | 206,000,000 | 258,000,000 | 174,000,000 | 231,000,000 | 238,000,000 | 236,000,000 | 145,000,000 | 158,000,000 | 101,156,000 | 83,984,000 | 145,146,000 | 84,502,000 | 82,056,000 | 82,849,000 | 147,451,000 | 90,442,000 | 93,154,000 | 8,375,000 | 11,675,000 | 12,700,000 | 6,877,000 | 11,062,000 | 16,158,000 | 7,782,000 | 15,906,000 | 13,618,000 | |||||
other | 433,000,000 | 478,000,000 | 485,000,000 | 483,000,000 | 479,000,000 | 493,000,000 | 378,000,000 | 335,000,000 | 354,000,000 | 472,000,000 | 427,000,000 | 463,000,000 | 418,000,000 | 572,000,000 | 433,000,000 | 447,000,000 | 476,000,000 | 1,265,000,000 | 1,163,000,000 | 1,003,000,000 | 980,000,000 | 2,009,000,000 | 1,877,000,000 | 503,000,000 | 532,000,000 | 420,000,000 | 415,000,000 | 419,000,000 | 468,000,000 | 740,000,000 | 416,000,000 | 435,000,000 | 367,807,000 | 301,240,000 | 377,102,000 | 115,204,000 | 78,162,000 | ||||||||||||||||||||||
total current liabilities | 2,208,000,000 | 2,178,000,000 | 2,295,000,000 | 2,370,000,000 | 2,345,000,000 | 2,126,000,000 | 2,172,000,000 | 2,136,000,000 | 2,142,000,000 | 2,149,000,000 | 2,076,000,000 | 2,132,000,000 | 2,186,000,000 | 2,383,000,000 | 2,295,000,000 | 2,347,000,000 | 2,364,000,000 | 3,090,000,000 | 2,869,000,000 | 2,710,000,000 | 2,815,000,000 | 3,629,000,000 | 3,422,000,000 | 2,165,000,000 | 2,282,000,000 | 2,355,000,000 | 2,503,000,000 | 2,508,000,000 | 2,392,000,000 | 2,479,000,000 | 2,062,000,000 | 2,263,000,000 | 2,277,000,000 | 2,378,000,000 | 2,996,000,000 | 3,054,000,000 | 1,996,409,000 | 1,911,139,000 | 1,703,160,000 | 1,662,742,000 | 1,605,829,000 | 1,642,040,000 | 1,580,004,000 | 1,428,883,000 | 1,313,878,000 | 1,302,626,000 | 1,447,935,000 | 1,389,508,000 | 611,024,000 | 590,716,000 | 575,283,000 | 546,815,000 | 533,786,000 | 472,596,000 | 437,403,000 | 440,334,000 | 436,028,000 | 422,816,000 | 419,606,000 |
long-term debt | 10,380,000,000 | 10,589,000,000 | 10,840,000,000 | 11,303,000,000 | 11,432,000,000 | 11,467,000,000 | 11,504,000,000 | 11,533,000,000 | 11,466,000,000 | 11,820,000,000 | 11,728,000,000 | 11,696,000,000 | 11,614,000,000 | 11,943,000,000 | 12,183,000,000 | 12,154,000,000 | 12,109,000,000 | 11,976,000,000 | 11,926,000,000 | 11,897,000,000 | 12,093,000,000 | 12,860,000,000 | 13,106,000,000 | 13,525,000,000 | 13,385,000,000 | 13,286,000,000 | 13,393,000,000 | 13,385,000,000 | 13,392,000,000 | 13,535,000,000 | 13,673,000,000 | 13,855,000,000 | 13,901,000,000 | 14,702,000,000 | 14,687,000,000 | 16,665,000,000 | 9,243,616,000 | 8,782,798,000 | 8,768,677,000 | 8,781,443,000 | 8,794,146,000 | 8,808,382,000 | 8,816,223,000 | 8,888,782,000 | 8,889,915,000 | 8,886,355,000 | 9,077,367,000 | 9,083,383,000 | 1,974,240,000 | 1,900,849,000 | 1,905,781,000 | 1,786,358,000 | 1,656,983,000 | 1,516,269,000 | 1,648,500,000 | 1,787,293,000 | 1,791,221,000 | 1,794,912,000 | 1,760,518,000 |
long-term operating lease liabilities | 537,000,000 | 527,000,000 | 514,000,000 | 535,000,000 | 535,000,000 | 528,000,000 | 542,000,000 | 546,000,000 | 563,000,000 | 560,000,000 | 580,000,000 | 588,000,000 | 605,000,000 | 563,000,000 | 569,000,000 | 578,000,000 | 535,000,000 | 538,000,000 | 515,000,000 | 528,000,000 | 524,000,000 | 523,000,000 | 508,000,000 | 514,000,000 | 487,000,000 | 497,000,000 | 479,000,000 | 495,000,000 | |||||||||||||||||||||||||||||||
other long-term liabilities | 891,000,000 | 866,000,000 | 850,000,000 | 806,000,000 | 828,000,000 | 815,000,000 | 721,000,000 | 726,000,000 | 739,000,000 | 694,000,000 | 722,000,000 | 647,000,000 | 644,000,000 | 726,000,000 | 759,000,000 | 790,000,000 | 827,000,000 | 914,000,000 | 1,190,000,000 | 1,475,000,000 | 1,599,000,000 | 951,000,000 | 913,000,000 | 846,000,000 | 894,000,000 | 998,000,000 | 987,000,000 | 977,000,000 | 1,008,000,000 | 1,051,000,000 | 1,329,000,000 | 1,352,000,000 | 1,399,000,000 | 1,456,000,000 | 1,469,000,000 | 1,723,000,000 | 986,022,000 | 949,990,000 | 975,163,000 | 1,026,069,000 | 952,406,000 | 1,001,675,000 | 1,038,229,000 | 617,350,000 | 571,085,000 | 679,722,000 | 483,459,000 | 416,530,000 | 205,408,000 | 195,429,000 | 160,370,000 | 144,221,000 | 132,013,000 | 139,818,000 | 126,159,000 | 123,357,000 | 115,540,000 | 99,717,000 | 58,468,000 |
total liabilities | 14,041,000,000 | 14,190,000,000 | 14,739,000,000 | 15,219,000,000 | 15,371,000,000 | 15,175,000,000 | 15,290,000,000 | 15,295,000,000 | 15,279,000,000 | 15,567,000,000 | 15,468,000,000 | 15,414,000,000 | 15,403,000,000 | 16,092,000,000 | 16,216,000,000 | 16,082,000,000 | 16,027,000,000 | 16,670,000,000 | 16,646,000,000 | 16,706,000,000 | 17,060,000,000 | 17,992,000,000 | 17,978,000,000 | 17,079,000,000 | 17,248,000,000 | 17,162,000,000 | 17,388,000,000 | 17,394,000,000 | 16,818,000,000 | 17,104,000,000 | 17,083,000,000 | 17,489,000,000 | 17,896,000,000 | 18,932,000,000 | 19,567,000,000 | 22,041,000,000 | 12,930,772,000 | 12,348,652,000 | 12,055,177,000 | 12,078,431,000 | 11,960,558,000 | 12,060,274,000 | 11,909,204,000 | ||||||||||||||||
redeemable noncontrolling interests in equity of consolidated subsidiaries | 322,000,000 | 323,000,000 | 314,000,000 | 364,000,000 | 359,000,000 | 322,000,000 | 324,000,000 | 329,000,000 | 323,000,000 | 329,000,000 | 583,000,000 | 561,000,000 | 541,000,000 | 516,000,000 | 498,000,000 | 493,000,000 | 480,000,000 | 493,000,000 | 498,000,000 | 481,000,000 | 484,000,000 | 481,000,000 | 489,000,000 | 502,000,000 | 502,000,000 | 498,000,000 | 503,000,000 | 505,000,000 | 504,000,000 | 495,000,000 | 514,000,000 | 523,000,000 | 530,000,000 | 548,000,000 | 552,000,000 | 565,000,000 | 363,540,000 | 395,743,000 | 383,745,000 | 376,658,000 | 385,438,000 | 387,472,000 | 384,056,000 | ||||||||||||||||
commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
community health systems, inc. stockholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, .01 par value per share... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, .01 par value per share... | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 919,000 | 915,000 | 918,000 | 932,000 | 949,000 | 936,000 | 937,000 | 967,000 | 969,000 | 972,000 | 966,000 | 966,000 | 959,000 | 957,000 | 950,000 | 961,000 | 958,000 | 994,000 | 945,000 | 895,000 | 912,000 | 901,000 | 882,000 | |||
additional paid-in capital | 2,185,000,000 | 2,183,000,000 | 2,184,000,000 | 2,176,000,000 | 2,175,000,000 | 2,194,000,000 | 2,190,000,000 | 2,192,000,000 | 2,185,000,000 | 2,170,000,000 | 2,049,000,000 | 2,054,000,000 | 2,084,000,000 | 2,091,000,000 | 2,090,000,000 | 2,107,000,000 | 2,118,000,000 | 2,092,000,000 | 2,084,000,000 | 2,105,000,000 | 2,094,000,000 | 2,005,000,000 | 2,008,000,000 | 2,001,000,000 | 2,008,000,000 | 2,004,000,000 | 2,002,000,000 | 2,007,000,000 | 2,017,000,000 | 2,011,000,000 | 2,013,000,000 | 2,014,000,000 | 2,002,000,000 | 1,984,000,000 | 1,980,000,000 | 1,952,000,000 | 1,089,447,000 | 1,086,008,000 | 1,084,415,000 | 1,119,205,000 | 1,149,002,000 | 1,126,751,000 | 1,126,498,000 | 1,258,637,000 | 1,251,746,000 | 1,247,241,000 | 1,240,308,000 | 1,227,623,000 | 1,215,321,000 | 1,202,476,000 | 1,195,947,000 | 1,226,854,000 | 1,215,495,000 | 1,334,789,000 | 1,208,930,000 | 1,046,198,000 | 1,109,052,000 | 1,085,441,000 | 1,037,196,000 |
accumulated other comprehensive loss | -9,000,000 | -5,000,000 | -5,000,000 | -7,000,000 | -10,000,000 | -8,000,000 | -13,000,000 | -16,000,000 | -14,000,000 | -23,000,000 | -19,000,000 | -18,000,000 | -21,000,000 | -33,000,000 | -27,000,000 | -22,000,000 | -14,000,000 | -14,000,000 | -15,000,000 | -16,000,000 | -13,000,000 | -5,000,000 | -5,000,000 | -9,000,000 | -10,000,000 | -10,000,000 | -8,000,000 | -9,000,000 | -16,000,000 | -45,000,000 | -53,000,000 | -54,000,000 | -89,000,000 | -170,136,000 | -184,479,000 | -201,051,000 | -200,533,000 | -192,640,000 | -230,927,000 | -288,660,000 | -93,367,000 | ||||||||||||||||||
accumulated deficit | -3,571,000,000 | -3,681,000,000 | -3,811,000,000 | -4,093,000,000 | -4,080,000,000 | -4,010,000,000 | -3,619,000,000 | -3,605,000,000 | -3,564,000,000 | -3,611,000,000 | -3,520,000,000 | -3,482,000,000 | -3,431,000,000 | -3,845,000,000 | -3,804,000,000 | -3,478,000,000 | -3,477,000,000 | -3,655,000,000 | -3,765,000,000 | -3,771,000,000 | -3,707,000,000 | -4,018,000,000 | -4,131,000,000 | -4,200,000,000 | -4,218,000,000 | -3,845,000,000 | -3,828,000,000 | -3,661,000,000 | -3,543,000,000 | -3,209,000,000 | -2,884,000,000 | -2,774,000,000 | -745,000,000 | -634,000,000 | -498,000,000 | ||||||||||||||||||||||||
total community health systems, inc. stockholders’ deficit | -1,394,000,000 | -1,502,000,000 | -1,631,000,000 | -1,923,000,000 | -1,914,000,000 | -1,823,000,000 | -1,441,000,000 | -1,428,000,000 | -1,392,000,000 | -1,463,000,000 | -1,489,000,000 | -1,445,000,000 | -1,367,000,000 | -1,786,000,000 | -1,740,000,000 | -1,392,000,000 | -1,372,000,000 | -1,576,000,000 | -1,695,000,000 | -1,681,000,000 | -1,625,000,000 | -2,017,000,000 | -2,127,000,000 | -2,205,000,000 | -2,218,000,000 | -1,848,000,000 | -1,833,000,000 | -1,663,000,000 | -1,535,000,000 | -1,205,000,000 | -879,000,000 | -775,000,000 | |||||||||||||||||||||||||||
noncontrolling interests in equity of consolidated subsidiaries | 235,000,000 | 228,000,000 | 219,000,000 | 230,000,000 | 238,000,000 | 231,000,000 | 238,000,000 | 221,000,000 | 245,000,000 | 241,000,000 | 86,000,000 | 93,000,000 | 92,000,000 | 92,000,000 | 84,000,000 | 80,000,000 | 82,000,000 | 83,000,000 | 79,000,000 | 86,000,000 | 87,000,000 | 60,000,000 | 75,000,000 | 69,000,000 | 77,000,000 | 83,000,000 | 74,000,000 | 73,000,000 | 72,000,000 | 75,000,000 | 76,000,000 | 74,000,000 | 96,000,000 | 95,000,000 | 112,000,000 | 115,000,000 | 61,748,000 | 67,349,000 | 60,997,000 | 61,305,000 | 60,944,000 | 60,913,000 | 64,264,000 | ||||||||||||||||
total stockholders’ deficit | -1,159,000,000 | -1,274,000,000 | -1,412,000,000 | -1,693,000,000 | -1,676,000,000 | -1,592,000,000 | -1,203,000,000 | -1,207,000,000 | -1,147,000,000 | -1,222,000,000 | -1,403,000,000 | -1,352,000,000 | -1,275,000,000 | -1,694,000,000 | -1,656,000,000 | -1,312,000,000 | -1,290,000,000 | -1,493,000,000 | -1,616,000,000 | -1,595,000,000 | -1,538,000,000 | -1,957,000,000 | -2,052,000,000 | -2,136,000,000 | -2,141,000,000 | -1,765,000,000 | -1,759,000,000 | -1,590,000,000 | -1,463,000,000 | -1,130,000,000 | -803,000,000 | -701,000,000 | |||||||||||||||||||||||||||
total liabilities and stockholders’ deficit | 13,204,000,000 | 13,239,000,000 | 13,641,000,000 | 13,890,000,000 | 14,054,000,000 | 13,905,000,000 | 14,411,000,000 | 14,417,000,000 | 14,455,000,000 | 14,674,000,000 | 14,648,000,000 | 14,623,000,000 | 14,669,000,000 | 14,914,000,000 | 15,058,000,000 | 15,263,000,000 | 15,217,000,000 | 15,670,000,000 | 15,528,000,000 | 15,592,000,000 | 16,006,000,000 | 16,516,000,000 | 16,415,000,000 | 15,445,000,000 | 15,609,000,000 | 15,895,000,000 | 16,132,000,000 | 16,309,000,000 | 15,859,000,000 | 16,469,000,000 | 16,794,000,000 | 17,311,000,000 | |||||||||||||||||||||||||||
prepaid expenses and taxes | 266,000,000 | 263,000,000 | 261,000,000 | 236,000,000 | 227,000,000 | 244,000,000 | 263,000,000 | 260,000,000 | 249,000,000 | 259,000,000 | 276,000,000 | 237,000,000 | 246,000,000 | 263,000,000 | 229,000,000 | 192,000,000 | 189,000,000 | 178,000,000 | 190,000,000 | 184,000,000 | 166,000,000 | 178,000,000 | 188,000,000 | 193,000,000 | 194,000,000 | 177,000,000 | 197,000,000 | 196,000,000 | 191,000,000 | 217,000,000 | 208,000,000 | 207,000,000 | 210,000,000 | 218,000,000 | 218,000,000 | 129,154,000 | 112,613,000 | 119,073,000 | 117,458,000 | 112,486,000 | 100,754,000 | 99,650,000 | 91,239,000 | 89,724,000 | 83,852,000 | 70,339,000 | 200,374,000 | 36,287,000 | 35,712,000 | 32,385,000 | 36,845,000 | 31,188,000 | 32,445,000 | 33,377,000 | 36,532,000 | 29,653,000 | 29,760,000 | 35,029,000 | |
other assets | 1,806,000,000 | 1,708,000,000 | 1,943,000,000 | 1,864,000,000 | 1,989,000,000 | 2,037,000,000 | 2,274,000,000 | 2,103,000,000 | 2,154,000,000 | 1,941,000,000 | 1,913,000,000 | 1,947,000,000 | 1,847,000,000 | 1,872,000,000 | 1,905,000,000 | 2,226,000,000 | 2,361,000,000 | 2,191,000,000 | 1,993,000,000 | 2,163,000,000 | 2,009,000,000 | 1,544,000,000 | 1,597,000,000 | 1,579,000,000 | 1,578,000,000 | 2,341,000,000 | 2,919,000,000 | 2,342,000,000 | 1,376,236,000 | 1,204,541,000 | 1,356,531,000 | 1,210,101,000 | 1,117,913,000 | 1,039,300,000 | 1,069,055,000 | 912,267,000 | 804,680,000 | 226,700,000 | 198,786,000 | 154,378,000 | 164,860,000 | 158,364,000 | 146,979,000 | 124,640,000 | 122,566,000 | 104,283,000 | |||||||||||||
income tax payable | 3,000,000 | 96,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.01 par value per share... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, 0.01 par value per share... | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 1,501 and 1,518 at december 31, 2024 and 2023, respectively | 2,175,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 1,518 and 1,392 at december 31, 2023 and 2022, respectively | 2,053,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 1,392 and 1,216 at december 31, 2022 and 2021, respectively | 2,007,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 1,216 and 1,118 at december 31, 2021 and 2020, respectively | 1,913,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 1,118 and 981 at december 31, 2020 and 2019, respectively | 1,896,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock,.01 par value per share... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock,.01 par value per share... | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
see accompanying notes to the condensed consolidated financial statements. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 981 and 939 at december 31, 2019 and 2018, respectively | 2,208,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 939 and 883 at december 31, 2018 and 2017, respectively | 1,543,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,538 and 3,773 at september 30, 2017 and december 31, 2016, respectively | 2,888,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued liabilities | 1,149,000,000 | 1,179,000,000 | 1,305,000,000 | 1,468,000,000 | 997,618,000 | 895,196,000 | 854,329,000 | 898,810,000 | 892,620,000 | 811,011,000 | 691,406,000 | 731,271,000 | 711,308,000 | 270,152,000 | 290,570,000 | 294,892,000 | 258,989,000 | 252,238,000 | 223,377,000 | 229,598,000 | 206,200,000 | 197,945,000 | |||||||||||||||||||||||||||||||||||||
equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
community health systems, inc. stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total community health systems, inc. stockholders’ equity | 1,213,000,000 | 1,298,000,000 | 1,429,000,000 | 4,003,000,000 | 2,490,356,000 | 2,397,096,000 | 2,348,003,000 | 2,309,021,000 | 2,311,339,000 | 2,189,464,000 | 2,061,969,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
total equity | 1,309,000,000 | 1,393,000,000 | 1,541,000,000 | 4,118,000,000 | 2,552,104,000 | 2,464,445,000 | 2,409,000,000 | 2,370,326,000 | 2,372,283,000 | 2,250,377,000 | 2,126,233,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and equity | 19,735,000,000 | 20,873,000,000 | 21,660,000,000 | 26,724,000,000 | 15,846,416,000 | 15,208,840,000 | 14,847,922,000 | 14,825,415,000 | 14,718,279,000 | 14,698,123,000 | 14,419,493,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,620 and 3,773 at june 30, 2017 and december 31, 2016, respectively | 2,939,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,729 and 3,773 at march 31, 2017 and december 31, 2016, respectively | 3,164,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 4,051 and 4,110 at march 31, 2016 and december 31, 2015, respectively | 3,723,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
treasury stock | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | -6,678,000 | |||||||||||||||||||||||||||||||||||||
retained earnings | 2,146,000,000 | 1,576,804,000 | 1,501,330,000 | 1,470,399,000 | 1,396,095,000 | 1,360,706,000 | 1,299,382,000 | 1,229,872,000 | 716,349,000 | 665,965,000 | 618,072,000 | 557,945,000 | 646,203,000 | 635,743,000 | 581,980,000 | 527,656,000 | 474,041,000 | 465,800,000 | 413,431,000 | 359,393,000 | 311,251,000 | 268,365,000 | 227,837,000 | ||||||||||||||||||||||||||||||||||||
current assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,996,090 and 1,891,334 at march 31, 2012 and december 31, 2011, respectively | 2,019,537,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
community health systems, inc. stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,891,334 and 1,639,198 at december 31, 2011 and december 31, 2010, respectively | 1,834,167,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment: - sum | 9,369,528,000 | 8,564,212,000 | 6,201,911,000 | 2,630,366,000 | 2,128,639,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 313,028 and 258,547 at december 31, 2011 and december 31, 2010, respectively | 1,241,930,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest | 110,121,000 | 146,415,000 | 153,832,000 | 7,122,000 | 8,591,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,840,003 and 1,639,198 at september 30, 2011 and december 31, 2010, respectively | 1,773,125,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current income tax payable | 17,705,000 | 349,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,793,404 and 1,639,198 at june 30, 2011 and december 31, 2010, respectively | 1,792,404,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,699,935 and 1,639,198 at march 31, 2011 and december 31, 2010, respectively | 1,766,122,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,639,198 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and 1,417,188 at december 31, 2010 and december 31, 2009, respectively | 1,714,542,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 258,547 and 197,880 in 2010 and 2009, respectively | 1,169,559,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,554,149 and 1,417,188 at september 30, 2010 and december 31, 2009, respectively | 1,651,406,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets cash and cash equivalents | 341,884,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,109,283 and 1,033,516 at september 30, 2008, and december 31, 2007, respectively | 1,642,820,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current income taxes payable | 38,312,000 | 12,224,000 | 49,010,000 | 25,524,000 | 7,626,000 | 50,289,000 | 31,822,000 | 19,811,000 | 21,983,000 | 27,120,000 | 22,666,000 | 39,676,000 | |||||||||||||||||||||||||||||||||||||||||||||||
minority interests in equity of consolidated subsidiaries | 343,472,000 | 320,587,000 | 384,129,000 | 366,131,000 | 372,954,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 1,875,908,000 | 1,834,109,000 | 1,671,570,000 | 1,710,804,000 | 1,846,913,000 | 1,860,967,000 | 1,780,450,000 | 1,723,673,000 | 1,708,640,000 | 1,698,299,000 | 1,763,027,000 | 1,564,577,000 | 1,350,839,000 | 1,363,122,000 | 1,301,410,000 | 1,185,762,000 | |||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity | 13,587,404,000 | 13,359,508,000 | 13,332,349,000 | 13,493,643,000 | 13,438,697,000 | 4,793,111,000 | 4,608,916,000 | 4,506,579,000 | 4,343,613,000 | 4,178,660,000 | 4,049,289,000 | 3,934,218,000 | 3,844,083,000 | 3,848,171,000 | 3,761,115,000 | 3,534,695,000 | |||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,052,811 and 1,033,516 at june 30, 2008, and december 31, 2007, respectively | 1,603,702,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -77,893,000 | -188,037,000 | -81,737,000 | -21,201,000 | 15,622,000 | 1,715,000 | 5,798,000 | 13,462,000 | 22,724,000 | 20,491,000 | 15,191,000 | 13,864,000 | 7,648,000 | 11,573,000 | 2,742,000 | ||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,036,766 and 1,033,516 at march 31, 2008, and december 31, 2007, respectively | 1,625,658,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,033,516 and 478,565 in 2007 and 2006, respectively | 1,533,798,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 100,556 and 92,921 in 2007 and 2006, respectively | 1,180,457,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unearned stock compensation | -13,204,000 | -14,691,000 | -16,177,000 | -17,664,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,001,570 and 478,565 at september 30, 2007, and december 31, 2006, respectively | 1,829,605,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 498,473 and 478,565 at june 30, 2007, and december 31, 2006, respectively | 876,523,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 497,354 and 478,565 at march 31, 2007, and december 31, 2006, respectively | 817,497,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 478,565 and 346,024 in 2006 and 2005, respectively | 773,984,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 92,921 and 78,599 in 2006 and 2005, respectively | 162,093,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 460,926 and 346,024 at september 30, 2006, and december 31, 2005, respectively | 745,538,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unearned stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 350,776 and 346,024 at june 30, 2006, and december 31, 2005, respectively | 727,688,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 340,847 and 346,024 at march 31, 2006 and december 31, 2005, respectively | 699,067,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 346,024 and 286,094 in 2005 and 2004, respectively | 656,029,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets, net of accumulated amortization of 78,599 and 71,017 in 2005 and 2004, respectively | 149,202,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 332,286 and 286,094 at september 30, 2005 and december 31, 2004, respectively | 629,862,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 300,313 and 286,094 at june 30, 2005 and december 31, 2004, respectively | 614,644,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 296,358 and 286,094 at march 31, 2005 and december 31, 2004, respectively | 606,541,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 282,320 and 103,677 at september 30, 2004 and december 31, 2003, respectively | 577,910,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated earnings | 151,620,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-03-31 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 160,000,000 | 171,000,000 | 320,000,000 | 25,000,000 | -20,000,000 | 446,000,000 | 1,000,000 | -298,000,000 | 30,000,000 | 222,000,000 | 144,000,000 | 37,000,000 | -35,000,000 | 257,000,000 | 128,000,000 | 92,000,000 | 34,000,000 | -346,000,000 | 2,000,000 | -299,000,000 | -307,000,000 | -91,000,000 | -122,000,000 | -177,000,000 | 36,000,000 | 99,252,000 | 53,120,000 | 92,631,000 | 53,547,000 | 78,325,000 | 92,249,000 | 50,384,000 | 47,893,000 | 60,127,000 | -88,258,000 | 10,460,000 | 53,763,000 | 54,324,000 | 53,615,000 | 8,241,000 | 52,369,000 | 54,038,000 | 48,142,000 | 42,886,000 | 40,528,000 | 35,988,000 | |||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 109,000,000 | 106,000,000 | 106,000,000 | 105,000,000 | 129,000,000 | 116,000,000 | 126,000,000 | 115,000,000 | 121,000,000 | 129,000,000 | 123,000,000 | 132,000,000 | 136,000,000 | 137,000,000 | 133,000,000 | 128,000,000 | 132,000,000 | 136,000,000 | 134,000,000 | 138,000,000 | 139,000,000 | 141,000,000 | 144,000,000 | 152,000,000 | 151,000,000 | 152,000,000 | 153,000,000 | 169,000,000 | 173,000,000 | 177,000,000 | 181,000,000 | 207,000,000 | 222,000,000 | 236,000,000 | 298,000,000 | 174,354,000 | 171,748,000 | 161,550,000 | 163,049,000 | 161,318,000 | 157,660,000 | 130,681,000 | 124,948,000 | 122,478,000 | 122,174,000 | 105,787,000 | 53,349,000 | 51,270,000 | 49,131,000 | 49,951,000 | 47,183,000 | 42,506,000 | 43,792,000 | 40,490,000 | 40,743,000 | 41,137,000 | |
deferred income taxes | 18,000,000 | -270,000,000 | 35,000,000 | -26,000,000 | 13,000,000 | -112,000,000 | -3,000,000 | -14,000,000 | 13,000,000 | -7,000,000 | 22,000,000 | 7,000,000 | -125,000,000 | 69,000,000 | 199,000,000 | 22,000,000 | 47,000,000 | 5,000,000 | 50,000,000 | 68,000,000 | 19,000,000 | -58,000,000 | -184,000,000 | ||||||||||||||||||||||||||||||||||
stock-based compensation expense | 4,000,000 | 0 | 3,000,000 | 4,000,000 | 5,000,000 | 4,000,000 | 2,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 4,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 3,000,000 | 5,000,000 | 7,000,000 | 5,000,000 | 5,000,000 | 8,000,000 | 3,000,000 | 3,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | 5,000,000 | 6,000,000 | 9,000,000 | 14,000,000 | 10,495,000 | 10,954,000 | 10,856,000 | 10,814,000 | 9,918,000 | 8,880,000 | 13,131,000 | 13,435,000 | 13,246,000 | 11,219,000 | 7,965,000 | 6,330,000 | 5,613,000 | 5,295,000 | 3,651,000 | |||||||
impairment and loss on sale of businesses | -164,000,000 | 21,000,000 | -239,000,000 | -24,000,000 | 7,000,000 | 267,000,000 | 10,000,000 | 17,000,000 | -78,000,000 | 26,000,000 | -13,000,000 | -22,000,000 | 17,000,000 | 6,000,000 | 0 | 1,000,000 | 2,000,000 | 21,000,000 | -8,000,000 | 11,000,000 | 45,000,000 | 38,000,000 | 28,000,000 | 250,000,000 | |||||||||||||||||||||||||||||||||
gain from early extinguishment of debt | 8,000,000 | 33,000,000 | 0 | 1,000,000 | 23,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash expenses | 39,000,000 | 42,000,000 | 47,000,000 | 45,000,000 | 46,000,000 | 48,000,000 | 61,000,000 | 33,000,000 | 49,000,000 | 44,000,000 | 46,000,000 | 42,000,000 | 42,000,000 | 45,000,000 | 50,000,000 | 45,000,000 | 56,000,000 | 25,000,000 | 37,000,000 | -40,000,000 | 26,000,000 | 24,000,000 | 49,000,000 | 42,000,000 | 39,000,000 | 65,000,000 | 36,000,000 | 13,000,000 | 2,000,000 | 11,000,000 | 12,000,000 | 6,000,000 | 10,000,000 | 8,000,000 | 14,000,000 | 2,569,000 | 14,437,000 | 9,966,000 | 15,486,000 | -11,173,000 | 4,266,000 | 2,770,000 | 17,197,000 | 3,362,000 | -1,674,000 | 132,000 | 463,000 | 668,000 | -41,000 | -590,000 | 923,000 | 328,000 | -40,000 | -471,000 | |||
changes in operating assets and liabilities, net of effects of acquisitions and divestitures: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable | 24,000,000 | 101,000,000 | 22,000,000 | -48,000,000 | -192,000,000 | 87,000,000 | 0 | 39,000,000 | -74,000,000 | -117,000,000 | 0 | -2,000,000 | -71,000,000 | 32,000,000 | 78,000,000 | -17,000,000 | -37,000,000 | -67,000,000 | 2,000,000 | -34,000,000 | -32,000,000 | 155,000,000 | 158,000,000 | 11,000,000 | -10,000,000 | -7,000,000 | 59,000,000 | 45,000,000 | -66,000,000 | 43,000,000 | 175,000,000 | 11,000,000 | -109,000,000 | -163,484,000 | -47,527,000 | -7,723,000 | -26,628,000 | -56,454,000 | -1,470,000 | -42,407,000 | 25,271,000 | -100,057,000 | 184,885,000 | -6,170,000 | -14,093,000 | -33,322,000 | -17,453,000 | 4,273,000 | -15,635,000 | -42,326,000 | -15,071,000 | -15,667,000 | -5,207,000 | -11,510,000 | |||
supplies, prepaid expenses and other current assets | 39,000,000 | 18,000,000 | -3,000,000 | -10,000,000 | -27,000,000 | -25,000,000 | 17,000,000 | -40,000,000 | 18,000,000 | -27,000,000 | -23,000,000 | -50,000,000 | -34,000,000 | -22,000,000 | -32,000,000 | -40,000,000 | -13,000,000 | -17,000,000 | 33,000,000 | -2,000,000 | -5,000,000 | 74,000,000 | -53,000,000 | -2,000,000 | -32,000,000 | 58,000,000 | 14,000,000 | 2,000,000 | 29,000,000 | 6,000,000 | -21,000,000 | 18,000,000 | 12,000,000 | -67,000,000 | -14,000,000 | -125,111,000 | -11,403,000 | -40,829,000 | -4,962,000 | 14,336,000 | -44,659,000 | -10,471,000 | 40,154,000 | -26,584,000 | -40,496,000 | 21,977,000 | -5,591,000 | -7,867,000 | 50,000 | -4,501,000 | -2,891,000 | 2,798,000 | -5,527,000 | -10,662,000 | -2,498,000 | 1,849,000 | |
accounts payable, accrued liabilities and income taxes | 50,000,000 | -132,000,000 | -57,000,000 | 103,000,000 | 256,000,000 | -31,000,000 | -75,000,000 | -13,000,000 | 19,000,000 | 61,000,000 | -98,000,000 | -32,000,000 | -68,000,000 | -27,000,000 | -40,000,000 | -23,000,000 | -69,000,000 | 87,000,000 | 21,000,000 | -23,000,000 | 79,000,000 | -82,000,000 | -78,000,000 | 158,000,000 | -342,000,000 | 4,000,000 | 23,000,000 | -116,000,000 | 261,000,000 | -275,000,000 | -33,000,000 | -89,000,000 | -112,000,000 | -14,000,000 | 64,000,000 | 96,109,000 | 99,944,000 | 16,648,000 | 144,456,000 | -14,938,000 | -10,735,000 | 101,127,000 | 165,833,000 | -81,965,000 | 80,209,000 | -603,000 | 665,000 | 45,688,000 | -3,834,000 | -14,003,000 | 41,617,000 | 28,371,000 | -10,310,000 | 4,399,000 | 24,842,000 | 66,025,000 | |
other | -21,000,000 | -21,000,000 | -8,000,000 | -54,000,000 | 7,000,000 | 66,000,000 | -37,000,000 | -41,000,000 | 2,000,000 | -34,000,000 | 23,000,000 | -56,000,000 | -41,000,000 | -74,000,000 | -40,000,000 | -60,000,000 | -49,000,000 | -40,000,000 | -34,000,000 | -53,000,000 | 24,000,000 | 17,000,000 | -66,000,000 | -143,000,000 | 2,000,000 | -45,000,000 | -59,000,000 | -19,000,000 | -15,000,000 | 0 | -2,000,000 | -25,000,000 | -32,000,000 | -34,000,000 | -27,000,000 | 30,701,000 | -21,249,000 | -7,658,000 | 1,834,000 | -748,000 | -13,098,000 | 16,632,000 | -18,219,000 | 21,119,000 | 2,928,000 | 7,073,000 | 2,169,000 | 4,357,000 | 19,050,000 | 12,163,000 | -11,892,000 | 2,176,000 | 1,575,000 | -4,607,000 | 19,996,000 | 8,013,000 | |
net cash from operating activities | 266,000,000 | 69,000,000 | 88,000,000 | 120,000,000 | 216,000,000 | 67,000,000 | 101,000,000 | 96,000,000 | 90,000,000 | 29,000,000 | 86,000,000 | 5,000,000 | 9,000,000 | 137,000,000 | 53,000,000 | 101,000,000 | -531,000,000 | 120,000,000 | 179,000,000 | 101,000,000 | -2,114,000,000 | 392,000,000 | 1,653,000,000 | 57,000,000 | 194,000,000 | -74,000,000 | 132,000,000 | 133,000,000 | -166,000,000 | 346,000,000 | -12,000,000 | 106,000,000 | 114,000,000 | 261,000,000 | 242,000,000 | 294,000,000 | 187,310,000 | 441,673,000 | 235,550,000 | 397,174,000 | 187,511,000 | 290,353,000 | 268,273,000 | 407,905,000 | 8,878,000 | 283,088,000 | 188,662,000 | 95,641,000 | 120,347,000 | 82,204,000 | 61,005,000 | 116,232,000 | 90,814,000 | 75,286,000 | 59,367,000 | 127,687,000 | 148,709,000 |
capital expenditures | -94,000,000 | -65,000,000 | -91,000,000 | -85,000,000 | -109,000,000 | -70,000,000 | -88,000,000 | -93,000,000 | -110,000,000 | -130,000,000 | -105,000,000 | -122,000,000 | -131,000,000 | -93,000,000 | -94,000,000 | -97,000,000 | -135,000,000 | -122,000,000 | -107,000,000 | -105,000,000 | 0 | -125,000,000 | -93,000,000 | -99,000,000 | -116,000,000 | -110,000,000 | -91,000,000 | -121,000,000 | -114,000,000 | -118,000,000 | -125,000,000 | -170,000,000 | -154,000,000 | -128,000,000 | -146,000,000 | -224,000,000 | -184,903,000 | -243,868,000 | -181,462,000 | -197,508,000 | -153,875,000 | -285,525,000 | -175,804,000 | -138,534,000 | -137,071,000 | -244,242,000 | -169,694,000 | -64,060,000 | -44,789,000 | -65,921,000 | -64,404,000 | -54,490,000 | -39,704,000 | -55,436,000 | -56,194,000 | -43,569,000 | -33,166,000 |
free cash flows | 172,000,000 | 4,000,000 | -3,000,000 | 35,000,000 | 107,000,000 | -3,000,000 | 13,000,000 | 3,000,000 | -20,000,000 | -101,000,000 | -19,000,000 | -117,000,000 | -122,000,000 | 44,000,000 | -41,000,000 | 4,000,000 | -666,000,000 | -2,000,000 | 72,000,000 | -4,000,000 | -2,114,000,000 | 267,000,000 | 1,560,000,000 | -42,000,000 | 78,000,000 | -184,000,000 | 41,000,000 | 12,000,000 | -280,000,000 | 228,000,000 | -137,000,000 | -64,000,000 | -40,000,000 | 133,000,000 | 96,000,000 | 70,000,000 | 2,407,000 | 197,805,000 | 54,088,000 | 199,666,000 | 33,636,000 | 4,828,000 | 92,469,000 | 269,371,000 | -128,193,000 | 38,846,000 | 18,968,000 | 31,581,000 | 75,558,000 | 16,283,000 | -3,399,000 | 61,742,000 | 51,110,000 | 19,850,000 | 3,173,000 | 84,118,000 | 115,543,000 |
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions of facilities and other related businesses | 0 | -24,000,000 | 0 | 0 | -1,000,000 | -3,000,000 | -20,000,000 | -7,000,000 | -8,000,000 | 0 | -5,000,000 | -3,000,000 | -1,000,000 | 0 | 1,000,000 | 0 | -4,000,000 | 0 | 0 | -9,000,000 | -4,000,000 | -5,000,000 | -11,000,000 | -2,000,000 | -8,000,000 | ||||||||||||||||||||||||||||||||
purchases of property and equipment | -94,000,000 | -65,000,000 | -91,000,000 | -85,000,000 | -109,000,000 | -70,000,000 | -88,000,000 | -93,000,000 | -110,000,000 | -130,000,000 | -105,000,000 | -122,000,000 | -131,000,000 | -93,000,000 | -94,000,000 | -97,000,000 | -135,000,000 | -122,000,000 | -107,000,000 | -105,000,000 | -125,000,000 | -93,000,000 | -99,000,000 | -116,000,000 | -110,000,000 | -91,000,000 | -121,000,000 | -114,000,000 | -118,000,000 | -125,000,000 | -170,000,000 | -154,000,000 | -128,000,000 | -146,000,000 | -224,000,000 | -184,903,000 | -243,868,000 | -181,462,000 | -197,508,000 | -153,875,000 | -285,525,000 | -175,804,000 | -138,534,000 | -137,071,000 | -244,242,000 | -169,694,000 | -64,060,000 | -44,789,000 | -65,921,000 | -64,404,000 | -54,490,000 | -39,704,000 | -55,436,000 | -56,194,000 | -43,569,000 | -33,166,000 | |
proceeds from disposition of hospitals and other ancillary operations | 242,000,000 | -1,000,000 | 450,000,000 | 563,000,000 | 0 | 309,000,000 | 12,000,000 | 19,000,000 | 92,000,000 | 86,000,000 | 0 | 1,000,000 | 2,000,000 | 0 | 10,000,000 | 1,000,000 | 6,000,000 | 195,000,000 | 150,000,000 | 2,000,000 | 241,000,000 | 202,000,000 | 0 | 161,000,000 | 177,000,000 | 140,000,000 | 77,000,000 | 11,000,000 | 745,000,000 | 12,000,000 | 809,000 | -278,000 | |||||||||||||||||||||||||
proceeds from sale of property and equipment | 0 | 3,000,000 | 0 | 1,000,000 | 3,000,000 | 1,000,000 | 1,000,000 | 3,000,000 | 19,000,000 | 5,000,000 | 8,000,000 | 23,000,000 | 3,000,000 | 4,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 0 | 1,000,000 | 3,000,000 | 1,000,000 | 3,000,000 | 1,000,000 | 4,000,000 | 748,000 | 1,909,000 | 1,217,000 | 447,000 | 7,587,000 | 5,556,000 | 1,075,000 | -828,000 | 13,717,000 | |||||||||||||||||||||||
purchases of available-for-sale debt securities and equity securities | -32,000,000 | -35,000,000 | -50,000,000 | -22,000,000 | -27,000,000 | -31,000,000 | -19,000,000 | -4,000,000 | -11,000,000 | -27,000,000 | -73,000,000 | -26,000,000 | -41,000,000 | -18,000,000 | -24,000,000 | -31,000,000 | -36,000,000 | -72,000,000 | -41,000,000 | -22,000,000 | -29,000,000 | -22,000,000 | -17,000,000 | ||||||||||||||||||||||||||||||||||
proceeds from sales of available-for-sale debt securities and equity securities | 36,000,000 | 29,000,000 | 35,000,000 | 23,000,000 | 26,000,000 | 22,000,000 | 20,000,000 | 12,000,000 | 11,000,000 | 84,000,000 | 76,000,000 | 61,000,000 | 48,000,000 | 21,000,000 | 17,000,000 | 24,000,000 | 16,000,000 | 38,000,000 | 22,000,000 | 26,000,000 | 37,000,000 | 22,000,000 | 21,000,000 | ||||||||||||||||||||||||||||||||||
purchases of investments in unconsolidated affiliates | -5,000,000 | 0 | 0 | -4,000,000 | -3,000,000 | -1,000,000 | -2,000,000 | -5,000,000 | -1,000,000 | -10,000,000 | -4,000,000 | -4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
increase in other investments | -10,000,000 | -11,000,000 | -7,000,000 | -35,000,000 | -4,000,000 | -21,000,000 | -24,000,000 | -10,000,000 | -14,000,000 | -22,000,000 | -13,000,000 | -16,000,000 | -21,000,000 | -9,000,000 | -16,000,000 | -14,000,000 | -52,000,000 | -27,000,000 | -11,000,000 | -23,000,000 | -17,000,000 | -3,000,000 | -16,000,000 | -24,000,000 | -49,000,000 | -63,000,000 | -34,000,000 | -65,000,000 | -23,000,000 | -25,000,000 | -28,000,000 | -35,000,000 | -23,000,000 | -37,000,000 | -67,000,000 | -67,708,000 | |||||||||||||||||||||
net cash from investing activities | 142,000,000 | -81,000,000 | 342,000,000 | 444,000,000 | -143,000,000 | 75,000,000 | -108,000,000 | -99,000,000 | 180,000,000 | -101,000,000 | -86,000,000 | -19,000,000 | -52,000,000 | 30,000,000 | -116,000,000 | -121,000,000 | -211,000,000 | -58,000,000 | -135,000,000 | -120,000,000 | 62,000,000 | 56,000,000 | -109,000,000 | 101,000,000 | 44,000,000 | -166,000,000 | 19,000,000 | 5,000,000 | -9,000,000 | -64,000,000 | -177,000,000 | 595,000,000 | 767,000,000 | -171,000,000 | -371,000,000 | -500,299,000 | -504,328,000 | -87,087,000 | -394,956,000 | -209,404,000 | -499,259,000 | -183,423,000 | -231,901,000 | 184,072,000 | -185,754,000 | -7,003,834,000 | -213,525,000 | -95,745,000 | -139,874,000 | -204,616,000 | -216,724,000 | -79,043,000 | -157,806,000 | -78,855,000 | -79,346,000 | -11,265,000 | |
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of restricted stock shares for payroll tax withholding requirements | 0 | 0 | -1,000,000 | -1,000,000 | 1,000,000 | 0 | 0 | -2,000,000 | 0 | 0 | 0 | -4,000,000 | 0 | 0 | 0 | -8,000,000 | 0 | 0 | 0 | -5,000,000 | 0 | 0 | -1,000,000 | 0 | 0 | 0 | -1,000,000 | -9,032,000 | |||||||||||||||||||||||||||||
deferred financing costs and other debt-related costs | -7,000,000 | -7,000,000 | -1,000,000 | 1,000,000 | -1,000,000 | 0 | 0 | -73,000,000 | -3,000,000 | 0 | -90,000,000 | -220,000,000 | 0 | 0 | -32,000,000 | -18,000,000 | 0 | -3,000,000 | -25,000,000 | -3,000,000 | -39,000,000 | -43,000,000 | -11,000,000 | -4,000,000 | -22,000,000 | -40,000,000 | |||||||||||||||||||||||||||||||
proceeds from noncontrolling investors in joint ventures | 0 | 1,000,000 | 0 | 0 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 3,000,000 | 9,000,000 | 0 | 1,000,000 | 0 | 8,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 0 | 0 | 5,000,000 | 0 | 366,000 | 0 | 863,000 | 2,046,000 | |||||||||||||||||||||||||||||||
redemption of noncontrolling investments in joint ventures | -1,000,000 | 0 | -1,000,000 | 0 | 0 | 0 | -1,000,000 | -3,000,000 | -1,000,000 | -14,000,000 | -2,000,000 | -2,000,000 | -1,000,000 | -4,000,000 | -21,000,000 | -3,000,000 | -3,000,000 | -16,000,000 | -31,096,000 | -8,238,000 | -1,481,000 | -3,078,000 | -225,000 | -4,851,000 | |||||||||||||||||||||||||||||||||
distributions to noncontrolling investors in joint ventures | -44,000,000 | -24,000,000 | -61,000,000 | -35,000,000 | -34,000,000 | -37,000,000 | -34,000,000 | -50,000,000 | -33,000,000 | -25,000,000 | -39,000,000 | -44,000,000 | -20,000,000 | -32,000,000 | -44,000,000 | -29,000,000 | -26,000,000 | -29,000,000 | -45,000,000 | -21,000,000 | -27,000,000 | -27,000,000 | -30,000,000 | -21,000,000 | -21,000,000 | -30,000,000 | -27,000,000 | -22,000,000 | -22,000,000 | -29,000,000 | -23,000,000 | -26,000,000 | -25,000,000 | -28,000,000 | -18,000,000 | -27,038,000 | -6,166,000 | -19,850,000 | -14,745,000 | -15,333,000 | -26,243,000 | ||||||||||||||||
other borrowings | 25,000,000 | 1,000,000 | 0 | 15,000,000 | 7,000,000 | 0 | 1,000,000 | 17,000,000 | 9,000,000 | 1,000,000 | 0 | 29,000,000 | 13,000,000 | 1,000,000 | 7,000,000 | 27,000,000 | 10,000,000 | 31,000,000 | 16,000,000 | 3,000,000 | 0 | 17,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||
issuance of long-term debt | 0 | 1,770,000,000 | 0 | -60,000,000 | 0 | 0 | 0 | 1,535,000,000 | 0 | 0 | 1,440,000,000 | 2,870,000,000 | 0 | 0 | 1,462,000,000 | 553,000,000 | 455,000,000 | 194,000,000 | 1,840,000,000 | 0 | 0 | 900,000,000 | 2,200,000,000 | 1,025,000,000 | |||||||||||||||||||||||||||||||||
proceeds from abl facility | 0 | 832,000,000 | 1,250,000,000 | 939,000,000 | 1,101,000,000 | 756,000,000 | 973,000,000 | 933,000,000 | 886,000,000 | 763,000,000 | 712,000,000 | 815,000,000 | 0 | 0 | 540,000,000 | 177,000,000 | 0 | 0 | 25,000,000 | ||||||||||||||||||||||||||||||||||||||
repayments of long-term indebtedness | -244,000,000 | -2,892,000,000 | -2,292,000,000 | -1,088,000,000 | -1,143,000,000 | -807,000,000 | -2,228,000,000 | -885,000,000 | -2,172,000,000 | -695,000,000 | -700,000,000 | -757,000,000 | -673,000,000 | -190,000,000 | -13,000,000 | -1,480,000,000 | -11,000,000 | -19,000,000 | -1,363,000,000 | -3,033,000,000 | -154,000,000 | -393,000,000 | -1,871,000,000 | -937,000,000 | -517,000,000 | -208,000,000 | -1,895,000,000 | -164,000,000 | -1,160,000,000 | -620,000,000 | -89,000,000 | -855,000,000 | -1,590,000,000 | -2,826,000,000 | -1,480,000,000 | -5,236,948,000 | -1,522,765,000 | -99,970,000 | -14,133,000 | -14,665,000 | -14,524,000 | -1,509,000 | -2,255,000 | -188,743,000 | -75,393,000 | -1,999,053,000 | -59,547,000 | -5,032,000 | -429,653,000 | -177,177,000 | -39,375,000 | -3,885,000 | -3,274,000 | -3,564,000 | -6,676,000 | -13,025,000 | |
net cash from financing activities | -271,000,000 | -321,000,000 | -405,000,000 | -170,000,000 | -69,000,000 | -148,000,000 | -2,000,000 | 13,000,000 | -323,000,000 | 45,000,000 | -26,000,000 | 40,000,000 | -139,000,000 | -213,000,000 | -51,000,000 | -27,000,000 | -45,000,000 | -18,000,000 | -45,000,000 | -406,000,000 | 516,000,000 | -183,000,000 | -403,000,000 | 82,000,000 | -236,000,000 | -20,000,000 | -36,000,000 | -71,000,000 | 22,000,000 | -210,000,000 | -140,000,000 | -68,000,000 | -887,000,000 | -507,000,000 | -62,000,000 | 74,000,000 | 312,422,000 | -73,792,000 | -73,583,000 | -81,502,000 | -6,560,000 | -59,674,000 | -7,038,000 | -76,285,000 | -161,471,000 | -83,315,000 | 6,912,670,000 | 76,363,000 | -2,290,000 | 84,792,000 | 132,898,000 | 12,698,000 | -3,928,000 | 2,348,000 | -68,596,000 | 5,576,000 | -1,495,000 |
net change in cash and cash equivalents | 137,000,000 | -333,000,000 | 25,000,000 | 394,000,000 | 4,000,000 | -6,000,000 | -9,000,000 | 10,000,000 | -53,000,000 | 26,000,000 | -182,000,000 | -46,000,000 | -114,000,000 | -47,000,000 | -787,000,000 | 44,000,000 | -1,000,000 | -425,000,000 | 271,000,000 | 1,306,000,000 | 30,000,000 | 59,000,000 | -50,000,000 | -70,000,000 | 81,000,000 | -139,000,000 | 127,000,000 | -216,000,000 | -139,000,000 | -178,000,000 | 521,000,000 | 9,000,000 | -567,000 | -136,447,000 | 74,880,000 | -79,284,000 | -28,453,000 | -268,580,000 | 77,812,000 | 99,719,000 | 31,479,000 | 14,019,000 | 97,498,000 | -41,521,000 | 22,312,000 | 27,122,000 | -10,713,000 | -87,794,000 | 7,843,000 | -80,172,000 | -88,084,000 | 53,917,000 | 135,949,000 | ||||
cash and cash equivalents at beginning of period | 0 | 0 | 0 | 37,000,000 | 0 | 0 | 0 | 38,000,000 | 0 | 0 | 0 | 118,000,000 | 0 | 0 | 0 | 507,000,000 | 0 | 0 | 0 | 1,676,000,000 | 0 | 0 | 216,000,000 | 0 | 0 | 0 | 196,000,000 | 0 | 0 | 0 | 563,000,000 | 0 | 0 | 238,000,000 | 184,000,000 | 129,865,000 | 0 | 0 | 0 | 299,169,000 | 0 | 0 | 0 | 132,874,000 | 0 | 0 | 0 | 40,566,000 | 0 | 0 | 0 | 104,108,000 | 0 | 0 | 0 | 82,498,000 | |
cash and cash equivalents at end of period | 137,000,000 | -333,000,000 | 25,000,000 | 431,000,000 | 4,000,000 | -6,000,000 | -9,000,000 | 48,000,000 | -53,000,000 | -27,000,000 | -26,000,000 | 144,000,000 | -182,000,000 | -46,000,000 | -114,000,000 | 460,000,000 | -787,000,000 | 44,000,000 | -1,000,000 | 1,251,000,000 | 271,000,000 | 1,306,000,000 | 246,000,000 | 59,000,000 | -50,000,000 | -70,000,000 | 277,000,000 | -139,000,000 | 127,000,000 | -216,000,000 | 424,000,000 | -178,000,000 | 521,000,000 | 247,000,000 | 181,000,000 | 129,298,000 | -136,447,000 | 74,880,000 | -79,284,000 | 270,716,000 | -268,580,000 | 77,812,000 | 99,719,000 | 164,353,000 | 14,019,000 | 97,498,000 | -41,521,000 | 62,878,000 | 27,122,000 | -10,713,000 | -87,794,000 | 111,951,000 | -80,172,000 | -88,084,000 | 53,917,000 | 218,447,000 | |
supplemental disclosure of cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest payments | -182,000,000 | -215,000,000 | -178,000,000 | -229,000,000 | -179,000,000 | -202,000,000 | -211,000,000 | -149,000,000 | -218,000,000 | -198,000,000 | -188,000,000 | -197,000,000 | -221,000,000 | -204,000,000 | -168,000,000 | -242,000,000 | -206,000,000 | -268,000,000 | -101,000,000 | -203,000,000 | -279,000,000 | -222,000,000 | -264,000,000 | -201,000,000 | -492,000,000 | -129,000,000 | -189,000,000 | -299,000,000 | -151,000,000 | -274,000,000 | -212,000,000 | -221,000,000 | -130,000,000 | -279,000,000 | -307,000,000 | 161,140,000 | 132,345,000 | 220,642,000 | 101,593,000 | 226,124,000 | 101,259,000 | ||||||||||||||||
income tax payments, net of refunds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax payments | -91,000,000 | -48,000,000 | -24,000,000 | 0 | -4,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refunds (payments) | 80,000,000 | -4,000,000 | 0 | 2,000,000 | 0 | 0 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
gain from coretrust transaction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution of coretrust transaction proceeds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -6,000,000 | -52,000,000 | -101,000,000 | -6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from (used in) operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from early extinguishment of debt | -180,000,000 | 5,000,000 | 0 | 0 | 8,000,000 | 71,000,000 | -115,000,000 | 0 | 4,000,000 | 31,000,000 | 4,000,000 | 21,000,000 | 63,429,000 | ||||||||||||||||||||||||||||||||||||||||||||
gain on sale of equity interests in macon healthcare, llc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment/derecognition of medicare accelerated payments | -814,000,000 | -133,000,000 | -116,000,000 | -18,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity interests in macon healthcare, llc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax (payments) refunds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution of coretrust proceeds | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
medicare accelerated payments | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pandemic relief funds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale-leaseback | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment and (gain) loss on sale of businesses | -1,000,000 | 354,000,000 | 112,000,000 | 33,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
income from early extinguishment of debt | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
medicare | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
medicaid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
managed care and other third-party payors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
self-pay | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash (used in) provided by operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
government and other legal settlements and related costs | 0 | 2,000,000 | 2,000,000 | 26,000,000 | 16,000,000 | 4,000,000 | 5,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 5,000,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale-lease back | 0 | 0 | 2,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of investments in unconsolidated affiliates | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of investments in unconsolidated affiliates | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in other comprehensive income of affiliates, net of income taxes: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in fair value of interest rate swaps, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in fair value of available-for-sale debt securities, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization and recognition of unrecognized pension cost components, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: comprehensive income attributable to noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income attributable to community health systems, inc. stockholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
see note to condensed financial statements of parent company. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
parent company only | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
condensed statements of cash flows | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in intercompany balances with affiliates | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrecognized pandemic relief funds | 155,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
see accompanying notes to the condensed consolidated financial statements. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals sold or held for sale | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of hma legal settlement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
borrowings under credit agreements | 11,000,000 | 3,000,000 | 11,000,000 | 12,000,000 | 4,000,000 | -2,000,000 | 16,000,000 | 10,000,000 | -1,000,000 | 230,000,000 | 610,000,000 | 1,564,000,000 | 4,315,011,000 | ||||||||||||||||||||||||||||||||||||||||||||
purchases of available-for-sale securities and equity securities | -19,000,000 | -24,000,000 | -15,000,000 | -28,000,000 | -12,000,000 | -19,000,000 | -19,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of available-for-sale securities and equity securities | 20,000,000 | 20,000,000 | 32,000,000 | 39,000,000 | 12,000,000 | 29,000,000 | 34,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) income from early extinguishment of debt | 1,000,000 | 27,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution from quorum health corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from abl and receivables facility | 210,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from receivables facility | 49,000,000 | 0 | 0 | 26,000,000 | 31,000,000 | 300,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions of facilities and other related equipment | -99,000,000 | -248,436,000 | -205,909,000 | -5,187,000 | -158,842,000 | -45,422,000 | -180,710,000 | -628,000 | -4,941,000 | -1,705,000 | -35,949,000 | -6,794,144,000 | -143,916,000 | -44,039,000 | -67,231,000 | -139,372,000 | -160,567,000 | -17,448,000 | -97,426,000 | ||||||||||||||||||||||||||||||||||||||
purchases of available-for-sale securities | -48,000,000 | -25,000,000 | -12,000,000 | -37,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of available-for-sale securities | 86,000,000 | 21,000,000 | 26,000,000 | 40,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
government settlement and related costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale | -728,000 | 66,000 | 0 | 3,234,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 17,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options | 308,000 | 30,000 | 49,000 | 706,000 | 18,125,000 | 3,077,000 | 331,000 | 1,263,000 | 94,000 | 410,000 | 1,111,000 | 3,382,000 | 3,311,000 | 1,988,000 | 3,886,000 | 6,780,000 | 1,919,000 | 9,434,000 | 4,246,000 | 19,942,000 | 15,958,000 | ||||||||||||||||||||||||||||||||||||
cash flows from operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospital sold | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
excess tax benefit relating to stock-based compensation | -1,004,000 | 43,000 | 16,000 | -4,675,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of ancillary operations | 3,881,000 | 14,583,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred financing costs | -24,787,000 | -19,252,000 | 134,000 | -125,000 | -212,000 | -2,232,000 | 7,156,000 | -189,743,000 | -353,000 | -14,000 | -2,145,000 | 8,000 | 0 | -16,000 | -137,000 | -131,000 | -242,000 | -749,000 | |||||||||||||||||||||||||||||||||||||||
income tax refunds received | -61,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals sold and other long-lived assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on early extinguishment of debt | 0 | 97,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
(excess tax benefit) income tax payable increase relating to stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
excess tax benefit (income tax payable increase) relating to stock-based compensation | 110,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock buy-back | 0 | -35,788,000 | -6,029,000 | -6,902,000 | -38,650,000 | 0 | -129,554,000 | -8,112,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
borrowings under credit agreement | 495,236,000 | 7,939,000 | -2,343,000 | 25,000,000 | -11,704,000 | 9,101,331,000 | 552,000,000 | 303,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals sold and held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in other non-operating assets | -55,769,000 | -42,934,000 | -32,277,000 | -38,580,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax (refunds received) paid | 22,989,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospitals held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets of hospital held for sale | 8,368,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes (refunds received) paid | -677,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospitals and partnership interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(excess tax benefit) income tax payable increase relating to stock-based compensation | -110,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on early extinguishment of debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived and other assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid (refunds received) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interest in earnings | 10,360,000 | 8,317,000 | 9,682,000 | 10,667,000 | 4,511,000 | 625,000 | 193,000 | 1,126,000 | 601,000 | 455,000 | 613,000 | 385,000 | 715,000 | 1,117,000 | 887,000 | ||||||||||||||||||||||||||||||||||||||||||
excess tax benefits relating to stock-based compensation | -2,225,000 | 0 | 947,000 | 1,059,000 | 20,000 | -1,537,000 | -758,000 | -230,000 | -2,001,000 | -228,000 | -4,360,000 | ||||||||||||||||||||||||||||||||||||||||||||||
increase in other assets | -7,788,000 | -87,831,000 | -56,549,000 | -40,663,000 | -18,311,000 | -7,051,000 | -6,890,000 | -5,078,000 | -1,957,000 | -22,425,000 | -5,011,000 | -7,761,000 | -14,842,000 | -7,237,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from minority investors in joint ventures | 438,000 | -1,667,000 | 12,881,000 | 1,163,000 | 83,000 | 86,000 | 1,019,000 | 1,600,000 | 2,230,000 | 0 | 3,060,000 | ||||||||||||||||||||||||||||||||||||||||||||||
redemption of minority investments in joint ventures | 0 | -17,000 | 30,000 | -116,000 | -1,253,000 | 0 | -385,000 | 0 | -530,000 | -2,925,000 | 0 | -27,000 | -290,000 | ||||||||||||||||||||||||||||||||||||||||||||
distributions to minority investors in joint ventures | -9,435,000 | -7,392,000 | -7,524,000 | -1,069,000 | -626,000 | -1,079,000 | -665,000 | -1,381,000 | -596,000 | -508,000 | -597,000 | -382,000 | |||||||||||||||||||||||||||||||||||||||||||||
gain on sale of hospitals | -326,000 | -12,885,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-cash expenses (gains) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
disposition of hospitals | 365,680,000 | 0 | 0 | 250,000 | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
stock compensation expense | 1,488,000 | 1,485,000 | 1,488,000 | 496,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment on hospital held for sale | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospitals | 0 | 0 | 0 | 3,937,000 | 0 | 0 | 6,295,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
disposition of hospitals and other ancillary operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equipment | 4,049,000 | 367,000 | 100,000 | 134,000 | 168,000 | 4,238,000 | 40,000 | 34,000 | 67,000 | 103,000 | 24,000 | 2,131,000 | |||||||||||||||||||||||||||||||||||||||||||||
redemption of convertible notes | 0 | 0 | 0 | -128,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
distribution to minority investors in joint ventures | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospital and partnership interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
disposition of hospital and other ancillary operations | 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
disposition of hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of senior subordinated notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of hospital held for sale | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of hospitals | 137,000 | 0 | 51,861,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock repurchases | -68,639,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from minority investments in joint ventures | 0 | 0 | 1,383,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquistions of facilities and other related equipment | -20,959,000 | -24,854,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock repurchase | -4,390,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of effects of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by financing activities |
